Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ACP1	"HAAP, LMW-PTP, LMWPTP"	ENSG00000143727	"Acid phosphatase 1"	P24666	2	264140-278283	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 913.9;Late spermatids: 1666.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016754	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		3700000	Nucleoplasm	Cytosol	"HPA016754: AB_1844505"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (6.67e-6)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (9.72e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.44e-2)"	22.3	59.7	38.0	20.8	40.3	38.0	33.0	27.9	43.7	23.1	29.7	27.4	24.4	31.1	25.2	36.2	24.8	29.5	26.9	27.4	34.6	33.7	42.1	54.8	24.7	29.4	31.5	34.6	33.7	53.0	28.4	43.9	39.7	39.7	27.0	32.8	28.5	46.0	23.8	35.4	21.6	34.5	24.2	28.6	28.1	34.2	38.3	21.2	33.0	32.5	32.8	29.8	22.7	20.3	33.9	20.3	17.3	23.0	35.3	41.0	33.1	17.8	26.6	41.5	22.8	18.8	18.8	33.7	21.7	23.1	21.7	19.2	36.5	18.0	11.2	16.9	20.3	28.5	17.5	40.3	23.6	19.6	27.3	41.0	32.8	24.1	79.8	26.1	37.2	18.9	19.2	21.5	20.3	25.2	23.0	24.6	42.0	33.1	21.9	25.6	24.2	40.0	36.0	50.1	47.2	30.0	26.6	42.1	25.6	33.9	25.5	45.3	44.8	13.5	32.0	43.4	28.3	18.9	19.9	20.3	23.9	15.9	19.7	32.7	29.8	59.1	34.9	28.3	32.2	28.1	17.3	19.8	17.1	30.1	22.7	39.7	33.9	34.3	34.4	17.7	31.1	41.0	39.7	3.5	35.3	23.0	20.3	35.6	33.1	38.0	40.3	27.9	43.7	34.6	33.7	31.5	34.6	39.7	21.2	41.7	88.5	101.3	80.3	70.3	51.3	74.2	109.5	129.8	67.1	64.6	7.9	179.7	228.8	194.3	913.9	64.7	84.9	163.5	146.5	234.8	71.9	111.0	68.2	112.0	123.7	27.0	79.2	50.3	57.7	1666.6	87.5	74.7	77.6	116.4	107.9	64.8	155.5	108.7	86.7	241.7	43.6	90.5	79.3	111.8	121.7	79.7	157.0	93.8	114.3	108.3
ACP4	ACPT	ENSG00000142513	"Acid phosphatase 4"	Q9BZG2	19	50790415-50795224	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Hydrolase	"Amelogenesis imperfecta, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"skin 1: 4.2;testis: 4.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.4;Karpas-707: 2.9;U-266/84: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.00e-3)"	"unprognostic (3.70e-3)"	"unprognostic (7.62e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.89e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.59e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.37e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.1	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.1		0.2	0.7	1.1	0.0	0.0		0.0	0.0		0.0	0.0	0.0	4.2	0.1	0.0	0.0	0.0	0.0	4.0			0.0		0.0	0.0	0.0	0.9	0.3	0.0	0.5	0.3	0.8	0.0	0.5	0.2	0.9	1.6	0.0	0.0	1.0	0.5	0.0	0.0	0.0	2.2	0.2	0.8	0.1	0.0	0.1	0.6	0.0	0.0	0.0	1.6	4.4	0.1	1.3	0.7	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	2.9	0.0	0.9	0.7	1.4	0.5	0.8	1.5	1.0	0.4	0.6	0.0	1.6	0.4	0.6	0.3	0.3	0.7	0.1	0.1	1.0	0.0	0.7	0.6	0.8	0.4	0.7	5.4	0.6	0.7	0.9	0.3	0.0	0.1	0.0	0.2	0.5	0.8	0.8	0.6	0.5	0.0	0.9	0.8	0.5	0.0	0.3	0.2	0.3	0.1	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ACP5	"HPAP, TRAP"	ENSG00000102575	"Acid phosphatase 5, tartrate resistant"	P13686	19	11574660-11579008	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 117.9;lung: 151.9"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 439.8;Ito cells: 434.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 51.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BEWO: 14.6;BJ hTERT+: 9.8;K-562: 10.3;RPMI-8226: 13.9;SK-MEL-30: 41.4;U-138 MG: 38.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002584, HPA057655, HPA059463"	Enhanced		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		3700000	Cytosol		"CAB002584: AB_564039, HPA057655: AB_2683490, HPA059463: AB_2684028"	"unprognostic (4.27e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.93e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.13e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.66e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	117.9	2.8	0.9	21.1	1.1	1.4	7.7	0.7	1.0	11.9	10.2	1.2	2.1	7.7	7.7	6.5	12.1	3.5	9.1	6.8	0.9	0.4	28.0	16.3	151.9	30.8	1.0	1.0	13.2	8.7	0.2	1.6	9.2	1.2	6.4	8.7	19.1	8.6	2.8	3.0	10.4	15.6	3.3	1.9	20.7	15.0	3.5	0.7	9.2	2.2	8.2	18.4	11.4	10.1	51.4	13.9	16.8	9.4	2.6	16.0	8.1	3.3	0.4	0.0	0.0	0.2	0.0	14.6	0.4	9.8	0.0	0.0	0.0	0.1	0.5	0.6	2.9	2.4	0.1	0.0	1.5	0.0	3.7	0.3	0.1	0.0	1.8	0.6	0.0	0.2	0.0	1.1	0.1	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.7	0.3	0.5	0.3	0.1	0.3	0.1	0.7	13.9	0.0	0.1	0.2	0.3	0.0	0.0	41.4	0.4	0.0	0.1	0.3	38.9	0.4	0.7	0.1	0.2	1.8	0.2	8.0	0.0	1.2	0.0	9.4	16.8	4.1	9.1	2.1	51.4	6.4	4.7	1.7	23.5	8.3	4.7	2.6	2.6	8.7	13.9	16.0	8.1	0.9	1.1	0.7	1.0	0.9	0.4	1.0	1.0	1.2	0.7	8.9	8.5	68.7	8.2	9.2	6.0	1.1	22.9	2.7	2.3	7.0	17.7	29.7	8.3	1.6	0.1	2.9	5.9	0.0	9.9	23.7	12.1	16.2	65.4	6.4	439.8	1.6	2.9	434.6	101.6	0.0	1.7	100.7	13.5	131.7	4.5	43.7	4.7	21.0	11.3	91.3	31.7	0.0	3.2	0.0	0.1	9.7	21.9	25.4	8.3	4.3
ACP6	"ACPL1, LPAP"	ENSG00000162836	"Acid phosphatase 6, lysophosphatidic"	Q9NPH0	1	147629652-147670496	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 38.9;RPTEC TERT1: 44.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028560	Uncertain				"Intracellular and membrane"	NA	NA		64000			"HPA028560: AB_10602427"	"unprognostic (3.17e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.50e-3)"	"unprognostic (3.36e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.94e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.44e-4)"	6.0	14.5	8.8	6.6	10.7	4.7	19.3	10.5	9.1	12.6	10.5	7.6	13.1	7.7	10.0	17.6	8.1	13.9	13.6	8.5	13.0	6.0	17.0	13.3	7.6	3.8	10.2	8.0	11.6	18.5	18.1	22.5	4.4	11.6	13.6	10.2	12.7	12.3	19.2	7.6	9.2	8.9	9.7	11.2	6.6	12.8	8.2	12.7	10.8	20.7	5.8	9.7	16.8	6.9	2.9	4.8	11.5	2.2	0.3	12.4	2.6	7.4	3.1	2.6	4.6	1.7	1.6	7.5	1.7	5.4	5.5	6.5	3.6	11.6	2.1	6.5	3.7	4.2	13.0	3.5	11.6	5.7	2.9	5.8	7.8	4.4	6.8	5.0	1.4	0.3	2.4	8.6	2.8	5.8	6.6	5.5	11.0	3.6	1.2	6.2	5.5	5.7	3.6	6.2	38.9	23.0	4.1	2.2	25.2	44.4	14.9	2.2	2.6	6.3	4.6	12.8	6.2	7.4	2.1	3.8	1.7	3.3	0.3	5.4	4.9	7.3	0.9	3.2	0.1	9.4	0.0	2.2	11.5	4.3	0.7	7.5	2.5	7.2	5.8	4.8	2.9	8.0	6.9	3.3	0.3	0.3	3.0	12.4	2.6	8.8	10.7	10.5	9.1	13.0	6.0	10.2	8.0	11.6	12.7	17.9	11.5	0.0	4.7	1.0	1.9	5.6	15.3	14.7	4.5	15.7	0.0	17.2	14.9	6.8	4.7	2.2	3.8	0.0	13.3	5.8	2.0	5.7	1.1	9.6	4.0	0.0	8.7	5.5	3.7	0.9	5.5	3.9	3.3	3.6	8.1	11.8	14.6	5.8	3.9	12.4	1.0	12.9	3.1	3.9	4.4	1.1	6.8	5.7	8.4	5.1
ACP7	"FLJ16165, PAPL, PAPL1"	ENSG00000183760	"Acid phosphatase 7, tartrate resistant (putative)"	Q6ZNF0	19	39083913-39111493	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 15.2;lymphoid tissue: 6.1;skin 1: 14.1;tongue: 5.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cervical cancer: 0.8;head and neck cancer: 2.6;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 21.5;U-87 MG: 28.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA042613	Uncertain				"Secreted - unknown location"	NA	NA					"HPA042613: AB_10963214"	"unprognostic (6.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.51e-5)"	"unprognostic (4.36e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.42e-1)"	0.3	0.3	1.6	0.3	5.5	0.3	1.0	15.2	5.4	0.9	0.3	4.2	0.3	0.4	0.4	1.4	1.1	0.3	0.9	0.3	2.5	1.2	0.3	0.3	0.4	0.3	6.5	0.7	0.3	0.3	0.3	0.0	0.3	5.2	1.2	0.3	0.0	0.6	0.3	0.3	14.1	0.3	0.3	4.1	0.3	0.6	0.4	5.3	0.0	0.3	5.5	6.1	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.4	0.5	0.3	3.2	0.0	0.0	0.0	21.5	0.2	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.9	0.7	0.0	0.0	0.0	0.0	0.0	28.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.5	15.2	5.4	2.5	1.2	6.5	0.7	5.2	5.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACPP	"ACP-3, ACP3, PAP"	ENSG00000014257	"Acid phosphatase, prostate"	P15309	3	132317367-132368298	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"prostate: 345.2"	"Cell type enriched"	"Detected in many"	135	"Glandular cells: 2098.0"	"Cancer enriched"	"Detected in many"	275	"prostate cancer: 1227.2"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 43.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.2;OE19: 12.7;RPMI-8226: 32.4;U-698: 9.4;U-87 MG: 9.0"	"Low region specificity"	"Detected in some"							"CAB000071, HPA004335, HPA063916"	Enhanced				"Secreted to blood"	NA	NA	460000	9200			"CAB000071: , HPA004335: AB_1079684, HPA063916: AB_2685152"	"unprognostic (6.67e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.71e-1)"	0.4	0.6	0.4	0.7	1.6	1.4	0.8	0.3	0.7	3.9	0.4	0.2	0.0	0.4	0.3	2.5	14.7	0.6	0.2	0.9	0.3	0.3	6.2	0.3	2.0	2.7	0.6	0.8	0.4	0.8	0.5	0.3	5.3	0.7	345.2	0.7	0.8	9.1	0.2	0.3	2.5	0.4	0.4	2.2	1.0	0.5	1.0	0.6	0.2	1.3	6.6	6.8	0.5	1.5	0.2	11.2	43.1	9.7	0.9	0.0	2.9	0.2	0.0	0.0	0.0	0.1	0.6	7.0	0.1	10.2	0.0	0.0	0.2	0.2	5.7	0.4	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	1.2	0.2	0.1	0.1	4.1	0.1	0.6	0.8	0.0	0.0	0.1	0.0	0.0	0.1	1.6	0.1	0.1	0.0	7.8	0.4	12.7	1.2	0.0	0.0	32.4	3.1	3.8	0.0	2.5	0.0	1.2	0.3	1.1	0.2	3.7	0.0	0.0	0.1	1.5	0.0	0.4	0.2	9.4	9.0	7.3	0.1	0.0	9.7	43.1	0.0	8.6	0.0	0.2	0.0	0.0	11.2	0.0	0.0	0.0	8.5	0.9	7.7	0.8	0.0	2.9	0.4	1.6	0.3	0.7	0.3	0.3	0.6	0.8	0.7	0.6	0.0	10.7	0.0	13.0	0.8	0.0	0.5	0.0	0.0	4.5	7.0	0.0	9.6	0.0	1.1	0.0	0.0	1.0	0.0	1.6	1.0	0.8	2098.0	0.0	0.0	4.1	0.0	15.5	0.0	9.2	0.0	0.0	2.8	0.0	0.0	2.4	0.3	1.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	7.4	0.0	1.0	11.5
AOX1	"AO, AOH1"	ENSG00000138356	"Aldehyde oxidase 1"	Q06278	2	200585868-200677064	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 228.8"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 649.9"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 122.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 85.8;ASC TERT1: 44.1;HSkMC: 17.7;hTERT-HME1: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040199, HPA040215"	Enhanced					NA	NA		410000			"HPA040199: AB_10795273, HPA040215: AB_10795360"	"unprognostic (4.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.17e-4)"	"unprognostic (1.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.00e-2)"	"prognostic favorable (6.05e-5)"	"unprognostic (1.33e-2)"	"unprognostic (8.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (4.99e-3)"	12.8	55.6	0.1	1.8	0.4	0.2	10.5	0.3	0.2	2.9	3.2	1.3	18.6	0.3	2.0	11.1	3.9	8.1	4.0	3.5	0.3	0.0	20.8	228.8	3.6	7.5	0.2	0.2	12.2	28.5	0.2	0.8	1.9	0.6	4.4	1.0	1.6	2.7	20.1	2.5	3.2	1.7	6.9	0.4	1.7	2.4	10.8	0.2	0.1	4.8	2.7	0.6	7.1	10.6	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0	85.8	44.1	0.0	1.4	2.6	1.1	2.1	0.0	0.0	0.0	0.1	1.7	0.5	0.0	0.0	3.9	4.8	0.0	0.1	0.0	1.0	4.3	5.7	0.2	0.0	17.7	1.0	5.6	17.7	1.1	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.0	1.7	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	6.8	3.0	2.4	0.0	0.5	0.0	0.0	0.6	2.3	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.3	0.2	0.3	0.0	0.2	0.2	0.6	0.2	3.0	0.6	13.7	0.5	1.5	0.0	0.7	12.7	0.0	0.0	3.5	0.0	0.0	10.0	0.6	0.5	1.3	0.0	0.0	22.4	0.1	10.2	8.3	0.0	649.9	0.4	0.0	2.9	15.4	20.2	0.9	68.4	1.6	3.3	0.0	0.0	0.4	18.4	0.0	77.1	111.5	0.0	0.0	2.8	0.7	0.6	1.4	0.0	0.0	0.0	0.3
ART1	"ART2, CD296"	ENSG00000129744	"ADP-ribosyltransferase 1"	P52961	11	3645128-3664416	"CD markers, Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	20	"skeletal muscle: 50.9;tongue: 13.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051148	Uncertain					NA	NA					"HPA051148: AB_2681363"	"unprognostic (3.73e-1)"							"unprognostic (4.58e-2)"		"unprognostic (3.12e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.06e-1)"		"unprognostic (1.73e-1)"		1.5	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.3	0.2	0.1	50.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	13.7	0.5	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ART3		ENSG00000156219	"ADP-ribosyltransferase 3"	Q13508	4	76011184-76112802	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"brain: 29.1;heart muscle: 55.1;skeletal muscle: 85.2;testis: 42.6;tongue: 27.2"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 65.9;Spermatocytes: 192.9"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Region enhanced"	"Detected in many"		"cerebellum: 29.1"	"Cell type enriched"	"Detected in single"	5	"gdT-cell: 1.9"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.9"	"Group enriched"	"Detected in some"	8	"NB-4: 6.2;NTERA-2: 16.9;SK-MEL-30: 7.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA011268	Enhanced				"Intracellular and membrane"	NA	NA		45000000			"HPA011268: AB_1845059"	"unprognostic (2.45e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.85e-4)"	"unprognostic (2.35e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.61e-3)"	3.5	0.6	4.9	0.9	1.9	0.4	0.7	29.1	9.0	1.0	1.3	6.0	0.0	0.6	0.5	1.1	2.5	0.5	0.5	55.1	3.0	0.9	0.5	0.5	0.6	0.5	3.9	2.0	0.5	3.8	0.4	1.1	0.5	2.7	1.0	1.4	0.4	1.3	1.0	85.2	0.5	0.8	0.6	3.0	1.5	0.9	42.6	7.2	0.0	0.5	27.2	0.5	0.6	0.7	0.0	0.0	0.1	0.0	0.0	1.9	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.2	16.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.4	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.9	1.9	29.1	9.0	3.0	0.9	3.9	2.0	2.7	7.2	0.0	0.0	0.0	0.4	0.5	0.4	65.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.4	0.0	0.0	0.0	0.1	0.4	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.0	1.7	0.0	1.7	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.3	0.0	3.1	192.9	19.4	0.3	0.0	0.0	0.0	0.4
ART4	"CD297, DO, DOK1"	ENSG00000111339	"ADP-ribosyltransferase 4 (Dombrock blood group)"	Q93070	12	14825569-14843533	"Blood group antigen proteins, CD markers, Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 33.7;lymphoid tissue: 17.8;placenta: 17.8"	"Cell type enhanced"	"Detected in many"	20	"Erythroid cells: 93.5;Hepatocytes: 21.3;Ito cells: 55.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.2;HEL: 10.3;Hep G2: 6.1;HUVEC TERT2: 23.4"	"Region enhanced"	"Detected in single"		"olfactory region: 2.2"	"Low region specificity"	"Detected in single"			HPA075664			Approved	"Rods & Rings"	"Secreted to blood"	NA	NA		11000000	"Rods & Rings"		"HPA075664: "	"unprognostic (2.50e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.62e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.71e-1)"	2.7	2.0	0.2	1.7	0.2	2.4	2.1	0.2	0.2	1.4	1.3	0.1	1.9	0.0	1.1	3.7	3.1	1.9	6.1	10.1	0.2	0.2	6.6	33.7	2.1	17.0	0.2	0.0	1.3	1.9	0.0	0.4	17.8	0.3	0.8	0.2	0.0	0.7	0.4	1.9	0.5	0.8	1.5	0.2	17.8	0.5	1.4	0.0	0.1	4.6	1.3	1.3	1.3	1.2	0.6	0.6	1.4	0.4	0.6	1.3	0.3	0.0	0.0	0.2	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	6.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.4	0.5	0.3	0.4	0.5	0.3	0.3	0.2	0.6	0.5	1.3	1.4	0.6	0.2	0.6	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.3	0.0	0.0	0.6	0.0	0.8	0.2	1.8	1.4	12.7	0.0	0.0	1.8	11.8	0.1	0.0	0.7	0.4	2.8	0.0	93.5	1.8	1.4	1.9	0.1	0.0	21.3	0.1	0.0	0.0	55.3	7.5	0.0	1.7	0.6	1.7	0.0	0.0	0.2	0.3	0.0	0.0	0.0	12.6	6.5	0.8	0.0	0.0	0.1	0.2	0.0	0.0	0.3
ART5		ENSG00000167311	"ADP-ribosyltransferase 5"	Q96L15	11	3638503-3642316	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 12.1;testis: 33.3"	"Group enriched"	"Detected in some"	4	"Early spermatids: 12.7;Late spermatids: 14.5;Spermatocytes: 15.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 4.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"memory CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Cell line enriched"	"Detected in some"	5	"SuSa: 17.9"	"Region enriched"	"Detected in single"	5	"olfactory region: 0.5"	"Not detected"	"Not detected"			"HPA041637, HPA044099"	Uncertain				"Secreted in other tissues"	NA	NA					"HPA041637: AB_2677589, HPA044099: AB_2678808"	"unprognostic (6.32e-2)"	"unprognostic (3.26e-5)"	"unprognostic (4.09e-3)"	"unprognostic (2.06e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.18e-1)"	0.8	0.1	0.3	0.3	0.5	0.0	0.8	0.3	0.6	3.3	0.3	0.3	1.0	0.0	3.3	0.9	0.4	1.5	1.2	2.9	0.3	0.2	0.7	0.6	0.9	0.3	0.3	0.3	9.3	0.3	1.7	0.6	1.7	0.5	1.1	0.0	5.3	1.2	0.8	12.1	0.3	0.4	1.0	0.3	0.5	0.3	33.3	0.5	0.3	3.5	5.2	0.5	0.5	1.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.0	2.2	0.0	0.0	3.7	0.2	1.8	0.9	2.1	0.1	0.0	0.0	0.9	0.2	0.0	0.0	1.8	0.0	0.5	0.0	2.6	0.0	0.4	0.2	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.3	0.0	0.1	0.6	0.0	0.2	0.4	0.0	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	1.8	0.1	17.9	0.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.6	0.3	0.2	0.3	0.3	0.5	0.5	0.0	2.6	0.0	1.8	0.2	0.4	1.6	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.4	12.7	0.3	0.0	0.0	0.2	0.4	0.7	0.6	0.0	1.7	0.1	0.0	0.0	0.0	0.3	14.5	3.1	0.0	0.0	0.0	0.0	3.3	0.2	0.0	1.1	0.3	0.7	0.0	0.2	15.9	1.7	0.3	2.4	0.0	0.0	0.1
BST1	CD157	ENSG00000109743	"Bone marrow stromal cell antigen 1"	Q10588	4	15702950-15738313	"CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 59.5;bone marrow: 54.9;intestine: 61.3"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 39.0;Kupffer cells: 36.4;Macrophages: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 52.7;neutrophil: 59.5"	"Group enriched"	"Detected in many"	105	"dendritic cells: 16.6;granulocytes: 59.5;monocytes: 52.7"	"Cell line enhanced"	"Detected in many"		"THP-1: 37.1;TIME: 20.4;U-937: 24.2;WM-115: 22.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050121	Uncertain				"Intracellular and membrane"	NA	NA		170000000			"HPA050121: AB_2681025"	"unprognostic (2.95e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.94e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.95e-1)"	14.3	2.0	1.1	5.6	2.0	54.9	6.6	0.8	1.5	7.2	33.8	1.5	2.1	20.4	6.4	7.0	4.6	5.6	10.3	14.5	1.8	0.8	6.6	3.7	9.4	9.6	1.3	1.9	5.5	1.0	0.4	1.3	8.0	1.3	7.5	4.0	5.4	2.8	2.2	3.4	3.5	61.3	7.9	1.5	13.6	2.4	2.4	1.2	2.8	3.5	2.9	1.8	7.5	16.1	0.4	16.6	59.5	52.7	0.1	0.3	19.6	0.2	5.5	0.5	0.4	13.5	3.2	0.7	10.5	1.0	9.6	10.8	0.1	5.7	0.3	0.9	5.3	0.2	0.1	1.5	0.2	8.2	0.3	0.2	2.5	0.3	0.2	3.4	3.3	7.3	2.7	0.7	6.1	0.5	0.4	1.5	2.3	0.3	0.2	5.6	0.1	1.0	1.9	1.2	0.4	1.1	0.3	0.7	0.2	0.3	0.3	0.7	2.1	0.2	0.3	7.0	0.5	0.2	37.1	20.4	0.3	0.5	3.7	0.4	0.2	0.0	0.3	1.3	24.2	22.1	7.6	52.7	3.9	0.2	19.8	0.3	0.4	0.1	0.1	16.6	0.2	0.2	0.1	59.5	0.1	13.6	5.5	0.2	19.6	1.1	2.0	0.8	1.5	1.8	0.8	1.3	1.9	1.3	1.2	3.0	3.0	0.0	0.8	4.0	0.2	0.8	5.1	2.7	1.2	1.8	0.0	14.0	1.7	4.1	2.7	2.1	3.2	0.0	2.3	18.7	18.6	0.5	16.1	1.8	39.0	0.0	1.2	3.7	36.4	0.7	2.8	29.9	13.5	0.0	7.0	0.3	0.8	7.0	2.1	6.7	0.0	6.5	10.8	2.3	1.2	2.6	5.9	0.0	16.6	2.7
CD38		ENSG00000004468	"CD38 molecule"	P28907	4	15778275-15853230	"Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins"		"Hydrolase, Receptor, Transferase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 94.9;seminal vesicle: 104.1"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 49.5;Erythroid cells: 46.7;granulocytes: 39.1;Kupffer cells: 31.1;T-cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 15.3"	"Group enriched"	"Detected in all"	4	"B-cells: 9.0;dendritic cells: 5.1;NK-cells: 15.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 50.8;Karpas-707: 14.2;MOLT-4: 12.8;REH: 10.3;U-266/70: 11.0;U-698: 9.6"	"Low region specificity"	"Detected in all"							"CAB002493, HPA022132, CAB025255, HPA052381"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807"	"unprognostic (1.27e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.06e-2)"	"prognostic favorable (9.68e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.15e-6)"	"unprognostic (5.23e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.63e-6)"	"unprognostic (1.79e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.13e-1)"	4.1	3.3	3.8	17.6	8.5	9.3	2.6	0.7	12.0	1.0	3.2	10.4	14.6	4.3	0.7	0.9	2.3	2.4	1.5	5.0	4.0	4.2	1.2	5.4	4.7	16.1	4.9	3.1	0.6	0.7	0.0	2.5	0.6	3.1	10.8	2.7	4.4	2.8	104.1	14.2	0.5	6.2	0.9	1.8	20.6	2.0	0.7	2.5	94.9	2.8	2.0	13.2	7.6	0.9	9.0	5.1	1.3	2.2	15.3	2.3	3.7	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	50.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.1	14.2	0.0	0.0	12.8	3.1	0.0	0.0	0.0	10.3	0.0	8.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.0	2.2	0.2	0.0	0.0	0.0	0.0	11.0	0.1	9.6	0.1	2.4	0.1	0.0	1.7	0.0	1.1	2.2	0.3	9.0	1.4	1.2	4.1	6.6	2.3	1.8	1.3	15.3	1.4	5.1	2.1	3.7	3.8	8.5	0.7	6.2	4.0	4.2	4.9	3.1	3.1	2.5	3.0	10.8	23.4	0.4	0.0	0.0	0.8	0.0	49.5	18.2	0.0	9.8	0.2	0.0	0.0	1.6	0.1	0.0	46.7	0.0	0.0	0.5	10.7	39.1	1.3	4.6	0.0	0.0	3.1	31.1	0.0	0.0	10.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	2.2	1.4	0.0	0.5	30.5	0.7	0.1
CYB5R1	"humb5R2, NQO3A2"	ENSG00000159348	"Cytochrome b5 reductase 1"	Q9UHQ9	1	202961869-202967280	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 119.2"	"Cell type enhanced"	"Detected in all"	6	"Basal keratinocytes: 166.3;Syncytiotrophoblasts: 245.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010641, HPA014147"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		860000	Mitochondria	Cytosol	"HPA010641: AB_1078600, HPA014147: AB_1847370"	"unprognostic (6.36e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (1.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.69e-1)"	9.6	14.5	7.8	5.0	8.4	3.9	16.9	6.2	11.0	11.6	7.5	8.7	10.6	4.4	10.1	32.3	13.7	16.4	9.2	33.9	7.3	9.2	15.5	18.4	10.1	11.7	10.0	9.1	10.8	11.1	16.3	11.1	63.8	11.9	10.5	5.0	15.7	14.4	10.1	119.2	28.5	6.9	10.6	7.4	10.8	18.6	20.1	6.7	11.7	13.5	26.4	10.0	13.6	10.1	20.2	21.9	25.7	33.3	17.2	26.5	28.8	8.5	5.3	4.7	9.6	43.9	10.1	46.1	17.1	16.2	11.2	10.0	4.4	10.1	5.3	14.6	17.1	6.2	47.3	3.8	14.7	7.4	7.6	9.7	3.0	6.5	5.0	15.8	2.6	7.6	16.2	48.7	12.3	6.7	9.5	7.3	6.6	8.9	9.6	40.2	10.0	3.2	2.3	3.1	7.7	10.3	5.4	22.7	11.3	10.6	10.2	4.0	5.0	9.6	32.0	13.9	10.7	14.8	5.8	7.1	12.8	5.4	4.8	9.5	9.0	10.6	2.5	14.1	4.0	9.5	11.6	33.3	25.6	16.7	24.2	22.2	13.6	19.3	17.8	21.9	20.2	26.5	18.8	25.7	17.2	15.7	15.1	19.1	28.8	7.8	8.4	6.2	11.0	7.3	9.2	10.0	9.1	11.9	6.7	20.8	24.3	13.0	30.5	166.3	19.6	98.7	33.1	58.9	20.5	27.9	27.5	100.3	6.6	35.7	4.3	29.5	11.9	23.3	41.7	159.6	29.6	19.2	27.7	36.0	54.2	9.5	18.4	23.4	39.9	5.4	27.6	33.5	60.8	9.0	10.9	56.4	53.6	10.5	29.4	32.1	25.9	12.9	34.0	24.6	2.7	137.6	245.4	17.5	14.2	47.8
CYB5R2		ENSG00000166394	"Cytochrome b5 reductase 2"	Q6BCY4	11	7665100-7677222	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 58.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 205.4;Late spermatids: 439.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 5.9;memory B-cell: 12.2"	"Group enriched"	"Detected in many"	9	"B-cells: 12.2;granulocytes: 5.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 42.5;BJ hTERT+ SV40 Large T+: 22.7;BJ hTERT+ SV40 Large T+ RasG12V: 20.7;HBF TERT88: 18.2;NTERA-2: 23.9;WM-115: 32.7"	"Low region specificity"	"Detected in many"							"HPA038962, HPA061707"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA038962: AB_10675954, HPA061707: AB_2732668"	"unprognostic (1.47e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.41e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.60e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.01e-2)"	3.3	1.9	9.3	2.8	12.1	1.9	7.7	3.1	12.3	6.6	2.3	26.1	4.2	1.3	10.0	13.1	8.0	5.2	3.4	2.0	11.2	5.3	2.4	2.5	4.6	3.8	22.3	7.3	14.9	2.2	23.1	0.6	6.7	11.6	7.8	2.7	12.2	12.8	11.6	0.8	23.4	1.7	6.8	12.4	2.0	2.2	58.8	14.5	0.2	2.6	6.7	4.9	5.9	7.1	12.2	0.0	5.9	1.0	0.0	0.2	0.7	2.3	1.2	0.5	0.0	0.1	0.6	7.9	14.8	42.5	22.7	20.7	0.2	3.2	0.0	3.5	7.6	7.0	0.2	0.0	0.1	18.2	0.0	0.0	0.0	1.3	0.3	12.3	0.1	2.3	6.2	0.5	0.1	1.2	0.0	1.9	0.0	2.2	0.0	0.1	0.0	0.0	0.0	23.9	2.4	1.1	11.2	0.0	0.0	0.0	1.5	0.0	0.2	0.1	9.5	0.6	4.0	1.6	3.1	0.0	2.1	0.0	0.1	1.1	0.0	0.0	3.5	0.1	0.0	32.7	0.0	1.0	5.9	0.0	0.5	0.0	12.2	0.2	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.7	9.3	12.1	3.1	12.3	11.2	5.3	22.3	7.3	11.6	14.5	20.8	3.2	0.0	7.4	6.3	0.8	1.9	0.0	8.1	2.3	3.5	19.6	4.6	0.0	1.4	205.4	1.0	0.0	0.0	4.2	16.5	7.1	4.8	2.3	1.1	2.3	0.0	0.0	0.0	0.0	439.8	4.4	1.4	5.0	0.0	1.4	0.8	4.6	0.9	5.6	0.0	37.7	12.9	12.6	63.0	5.9	8.8	3.8	0.0	1.4	10.5
CYB5R3	DIA1	ENSG00000100243	"Cytochrome b5 reductase 3"	P00387	22	42617840-42649568	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 117.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001566	Approved		Supported	"Endoplasmic reticulum"		NA	NA		67000000	"Endoplasmic reticulum"		"HPA001566: AB_1078601"	"unprognostic (4.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (2.13e-5)"	"unprognostic (2.45e-1)"	"unprognostic (8.22e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.24e-2)"	79.7	57.1	33.2	22.8	32.6	19.3	86.8	19.5	33.1	52.4	31.9	37.6	51.8	25.9	51.9	35.0	39.1	39.3	38.6	86.4	31.3	24.1	43.3	78.2	43.5	30.3	31.8	25.4	58.8	21.9	15.1	27.2	32.1	33.9	40.6	21.3	37.9	29.3	96.4	34.4	43.1	32.5	55.5	36.3	20.2	33.7	44.0	25.9	14.1	30.1	28.4	23.2	43.4	53.5	28.6	37.6	70.3	39.7	14.2	22.3	19.7	16.5	10.6	17.5	10.8	117.8	93.7	10.3	48.8	45.3	36.5	32.6	13.9	13.0	7.8	21.8	90.2	15.8	15.3	11.7	24.1	18.8	8.4	26.2	11.1	18.4	26.8	30.0	15.5	20.8	56.4	19.1	26.2	17.4	26.7	30.1	10.1	9.6	40.9	49.5	18.3	15.2	14.3	7.0	17.3	19.6	11.2	21.3	17.4	28.0	12.2	7.8	10.1	16.1	15.6	17.8	13.5	12.4	15.0	46.1	39.6	24.7	26.6	18.3	10.9	11.7	9.6	46.1	9.0	32.5	26.3	25.7	70.3	19.7	32.4	19.9	28.6	19.1	21.6	37.6	26.4	13.6	14.3	13.4	14.2	39.7	34.3	22.3	19.7	33.2	32.6	19.5	33.1	31.3	24.1	31.8	25.4	33.9	25.9	80.4	44.4	45.6	76.5	97.8	15.9	86.2	112.1	24.1	47.8	57.6	3.9	94.2	41.4	197.4	3.7	128.1	83.6	116.8	93.8	165.0	171.8	78.6	62.2	149.9	98.1	15.9	80.4	125.8	48.8	6.9	235.1	65.2	167.0	156.9	41.0	91.8	117.8	80.6	263.8	100.0	17.3	187.5	253.9	15.8	48.1	98.5	98.6	40.1	48.2	75.8
CYB5R4	"b5+b5R, dJ676J13.1, NCB5OR"	ENSG00000065615	"Cytochrome b5 reductase 4"	Q7L1T6	6	83859643-83967424	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 49.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 150.1;Late spermatids: 277.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 49.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 36.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018992	Approved					NA	NA					"HPA018992: AB_1847371"	"unprognostic (4.86e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.94e-2)"	"unprognostic (4.77e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.44e-1)"	"unprognostic (6.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.15e-2)"	9.3	8.2	4.5	17.9	9.1	23.1	9.6	11.5	8.4	6.3	10.5	8.0	6.2	10.0	7.2	7.6	11.1	6.1	5.3	10.8	4.9	5.0	8.7	8.6	12.3	23.4	10.2	3.4	6.0	8.5	3.6	10.5	12.6	7.3	6.5	8.2	4.3	9.3	4.3	11.9	6.6	11.0	8.8	12.2	18.8	10.8	21.6	9.7	14.2	5.6	6.6	11.9	10.9	7.6	6.9	11.4	49.6	14.6	3.3	5.6	6.3	5.1	4.5	3.2	4.1	1.8	2.4	6.0	3.5	5.2	5.2	7.6	5.8	3.5	9.4	5.5	2.1	14.3	4.3	2.9	4.8	4.0	36.1	6.5	22.7	2.7	3.2	3.4	13.5	20.5	3.0	1.3	3.5	3.7	2.1	2.6	8.5	8.1	7.2	3.7	2.0	3.6	3.8	1.8	4.1	4.2	6.0	11.8	3.4	2.3	5.4	8.5	4.7	4.2	4.2	4.8	2.1	2.4	8.1	3.4	5.3	4.4	10.8	11.0	8.3	12.7	5.2	6.1	9.4	5.8	20.8	14.6	42.2	4.4	12.1	3.5	6.9	3.8	3.9	11.4	6.6	2.5	3.9	49.6	3.3	13.1	4.8	5.6	6.3	4.5	9.1	11.5	8.4	4.9	5.0	10.2	3.4	7.3	9.7	6.0	15.2	26.7	12.4	9.8	12.6	13.4	10.2	13.4	10.3	7.0	15.7	4.8	10.0	22.8	150.1	8.3	13.5	0.0	22.1	16.9	8.2	11.7	24.3	10.5	42.4	12.7	15.5	4.3	52.6	277.8	7.8	46.0	15.1	45.9	13.5	5.7	21.9	14.0	7.1	16.1	19.3	6.5	11.4	23.0	27.4	12.9	9.6	25.4	14.0	17.7
CYB5RL	LOC606495	ENSG00000215883	"Cytochrome b5 reductase like"	Q6IPT4	1	54169651-54200036	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 9.4"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042671, HPA060463"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042671: AB_2678107, HPA060463: AB_2684286"	"unprognostic (2.03e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.90e-4)"	"unprognostic (6.45e-3)"	"unprognostic (9.75e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.86e-1)"	1.7	4.9	1.9	0.8	1.9	1.6	2.4	1.3	1.7	2.5	2.2			2.6	2.5	2.3	2.1	2.9	2.0	3.5	2.1	1.7	2.7	2.6	1.5	2.1	2.3		5.0	4.1	1.8	4.2	1.1		2.1	2.7		3.2	1.4	3.7	3.9	1.5	2.4	1.8	2.5	2.8	1.2			3.1		2.2	2.8	1.8	1.4	1.8	2.6	3.5	3.1	1.5	1.2	3.9	5.3	7.3	7.5	5.9	5.7	2.5	3.1	4.5	6.1	6.6	4.9	4.3	6.6	3.7	2.1	13.9	3.6	11.3	3.3	6.9	7.4	4.6	7.5	8.5	5.0	4.4	6.3	3.8	3.0	4.4	7.2	3.3	4.3	5.3	6.0	8.0	3.1	4.4	4.8	6.3	3.5	7.2	4.5	4.2	10.2	8.9	6.0	2.7	4.5	10.7	5.3	2.1	7.2	6.3	6.1	5.0	4.9	2.4	4.7	3.8	6.9	5.5	4.7	7.5	9.7	5.2	13.6	7.1	2.2	1.8	1.6	1.0	3.5	0.8	1.1	1.5	0.6	1.6	1.4	1.2	1.2	2.6	3.1	0.8	1.8	0.5	1.2											0.0	7.4	0.9	1.0	0.1	3.7	4.2	0.0	9.4	4.5	3.5	3.9	1.5	6.6	2.4	0.0	3.6	0.9	0.0	3.6	1.7	1.5	1.1	2.3	2.1	4.6	0.0	2.4	3.1	1.0	0.6	1.4	1.4	0.0	1.0	0.7	2.0	1.3	0.0	1.8	2.2	3.1	0.0	1.4	0.9	5.3	0.6	0.2	0.5	2.4	0.8
ENPP1	"M6S1, NPPS, PC-1, PCA1, PDNP1"	ENSG00000197594	"Ectonucleotide pyrophosphatase/phosphodiesterase 1"	P22413	6	131808016-131895155	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins"	Biomineralization	Hydrolase	"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Hepatocytes: 80.9;Peritubular cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"NK-cell: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 23.1;LHCN-M2: 13.8;U-138 MG: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB032904, HPA062066"	Enhanced				"Secreted - unknown location"	NA	NA		2500000			"CAB032904: AB_2099635, HPA062066: AB_2684674"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.22e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.28e-3)"	17.2	2.1	0.5	1.9	0.5	0.0	30.5	0.6	0.4	8.5	2.8	1.6	8.3	1.1	25.7	7.1	1.5	6.4	2.6	1.9	0.5	0.7	10.9	19.4	2.0	0.7	1.1	0.0	7.3	17.5	22.2	27.0	28.9	0.8	3.3	1.2	13.4	5.4	6.5	2.1	1.7	2.6	6.8	2.0	1.2	1.7	4.6	0.3	2.0	13.2	6.9	1.4	3.2	7.7	0.6	2.2	1.4	0.3	4.6	1.7	0.1	0.0	0.8	0.8	0.0	23.1	3.6	0.0	6.0	6.1	2.3	6.4	2.6	0.7	0.0	0.5	3.8	4.8	0.0	0.8	0.1	9.9	0.2	1.1	0.0	0.7	7.7	0.7	0.0	2.8	5.9	0.2	6.4	0.2	2.7	2.8	0.5	0.0	1.2	13.8	1.6	0.0	0.0	5.2	1.0	0.9	0.0	6.7	0.1	0.1	0.3	2.3	0.0	0.1	0.8	2.7	4.0	2.5	0.0	1.8	18.5	0.7	1.3	5.8	2.2	0.0	0.0	8.4	0.0	2.3	1.4	0.2	0.3	0.3	0.2	1.7	0.3	0.3	0.3	2.2	0.6	0.3	0.3	1.0	4.6	0.3	0.3	0.2	0.1	0.5	0.5	0.6	0.4	0.5	0.7	1.1	0.0	0.8	0.3	0.0	1.7	1.5	10.5	1.3	4.0	2.8	5.1	0.0	0.0	1.8	0.0	2.0	5.0	0.1	3.9	1.9	7.7	0.0	8.8	1.3	25.4	3.4	0.0	80.9	4.3	1.6	0.0	2.5	3.3	4.7	23.3	1.3	1.7	0.0	8.6	4.4	7.9	3.5	65.7	15.6	0.3	12.9	10.5	1.4	1.3	1.1	5.1	0.0	1.7	1.6
ENPP3	"B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3"	ENSG00000154269	"Ectonucleotide pyrophosphatase/phosphodiesterase 3"	O14638	6	131628442-131747418	"CD markers, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 29.0;intestine: 45.4;seminal vesicle: 70.7"	"Cell type enhanced"	"Detected in many"	20	"Enterocytes: 9.0;granulocytes: 33.7;Proximal tubular cells: 8.2"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 49.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	74	"basophil: 18.2"	"Lineage enriched"	"Detected in single"	74	"granulocytes: 18.2"	"Group enriched"	"Detected in some"	18	"HEL: 5.2;Hep G2: 17.0;HMC-1: 7.6"	"Low region specificity"	"Detected in some"							HPA043772	Enhanced				"Secreted - unknown location"	NA	NA		480000			"HPA043772: AB_10795616"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.86e-5)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.80e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.31e-3)"	0.8	7.9	0.5	2.0	0.5	0.0	4.0	2.1	0.4	19.0	18.5	0.2	29.0	9.3	6.2	7.2	0.5	2.3	1.8	0.2	0.4	0.7	11.9	2.7	1.7	0.2	0.5	0.2	0.9	0.2	0.0	0.5	0.4	0.2	3.7	4.8	0.6	14.9	70.7	0.2	0.8	45.4	1.9	0.4	0.5	0.7	1.0	0.2	4.1	0.5	1.2	0.5	0.9	1.2	0.0	0.0	18.2	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	5.2	0.0	17.0	0.0	0.1	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.5	2.1	0.4	0.4	0.7	0.5	0.2	0.2	0.2	0.0	1.4	0.0	2.8	0.0	0.0	0.2	0.0	2.7	1.2	0.0	0.0	0.0	1.7	0.0	1.3	0.3	9.0	0.0	0.0	0.0	0.5	4.6	33.7	1.7	0.1	0.0	0.0	0.6	0.6	0.0	1.1	0.2	1.7	0.0	1.1	0.0	0.0	2.3	0.7	8.2	0.0	0.0	0.0	1.8	0.8	0.5	0.1	0.5	5.2	1.1
HAAO		ENSG00000162882	"3-hydroxyanthranilate 3,4-dioxygenase"	P46952	2	42767089-42792593	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 78.7"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 199.6;Proximal tubular cells: 138.8"	"Group enriched"	"Detected in all"	5	"liver cancer: 46.5;renal cancer: 13.9"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 15.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 15.7;granulocytes: 12.6;monocytes: 11.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.0;Hep G2: 31.8;REH: 6.6;THP-1: 6.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA036394, HPA042024"	Enhanced					NA	NA		150000			"HPA036394: AB_10673131, HPA042024: AB_2677803"	"unprognostic (6.97e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.23e-3)"	"prognostic favorable (5.77e-4)"	"unprognostic (6.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.03e-1)"	2.9	1.8	1.6	6.8	1.2	0.7	3.5	0.4	1.1	5.8	11.9	1.9	3.5	5.8	3.6	6.2	2.7	3.2	2.7	2.2	0.9	0.8	10.9	78.7	1.8	2.1	1.4	1.6	5.0	8.6	1.7	1.6	3.8	1.4	6.5	2.9	12.1	1.4	3.1	0.9	1.6	24.5	6.5	1.5	1.8	2.4	1.7	0.9	1.6	2.0	1.3	1.9	4.3	3.2	2.8	15.7	12.6	11.8	0.5	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	3.1	9.0	0.1	0.0	0.1	0.4	0.0	0.0	3.2	0.0	0.5	0.0	1.1	3.6	0.0	31.8	0.3	1.2	0.1	1.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.8	0.1	0.0	6.6	0.7	0.1	0.0	0.0	0.1	0.0	0.4	0.7	0.0	0.9	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.7	11.8	12.6	0.0	7.0	0.0	2.2	0.0	0.0	15.7	2.8	0.0	0.0	3.7	0.5	1.8	5.1	0.0	3.5	1.6	1.2	0.4	1.1	0.9	0.8	1.4	1.6	1.4	0.9	0.0	1.4	0.9	5.2	3.5	0.0	0.4	12.7	0.0	0.0	1.8	0.0	1.0	14.9	5.1	0.0	0.5	20.2	0.0	11.5	0.6	8.4	2.0	30.0	199.6	18.5	0.0	6.4	4.9	12.9	0.0	11.5	4.9	5.0	7.2	8.7	2.1	7.7	18.1	9.9	138.8	0.2	12.9	12.3	0.1	0.5	4.3	1.0	1.7	11.3	1.6
IDH1		ENSG00000138413	"Isocitrate dehydrogenase (NADP(+)) 1, cytosolic"	O75874	2	208236227-208266074	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 277.8;Hepatocytes: 306.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 107.6;RT4: 75.1"	"Low region specificity"	"Detected in all"							"CAB033218, HPA035248, HPA057936, CAB062556"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA		16000000	"Nuclear bodies, Cytosol"		"CAB033218: AB_2123166, CAB062556: AB_2665593, HPA035248: AB_10600714, HPA057936: AB_2683559"	"unprognostic (2.79e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (3.32e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.03e-2)"	"unprognostic (5.54e-2)"	"unprognostic (4.18e-3)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.69e-2)"	41.3	82.3	6.2	8.8	7.0	1.3	20.9	6.5	8.3	12.6	35.2	8.7	38.0	30.6	8.0	29.9	30.3	8.8	18.7	10.8	6.3	6.2	20.5	91.0	19.8	14.3	8.1	4.7	19.4	21.5	4.8	6.2	24.1	8.7	38.5	23.1	15.4	18.7	39.0	4.7	7.4	54.1	10.1	9.3	21.3	20.4	15.6	8.4	3.5	7.9	11.0	11.9	43.4	12.1	4.9	22.8	6.4	31.6	7.4	6.6	12.0	9.5	16.1	23.0	9.3	41.8	29.9	13.1	4.0	18.3	6.7	16.4	25.4	23.4	1.9	25.4	12.4	28.6	14.8	16.5	19.3	6.5	1.3	6.2	8.2	13.2	107.6	55.7	5.3	8.2	25.7	41.0	15.4	11.2	10.7	18.5	5.6	8.2	6.6	10.3	6.1	3.8	9.2	42.0	68.5	6.6	3.6	8.4	5.4	30.4	75.1	3.9	6.9	15.2	14.7	49.7	25.4	5.6	15.7	12.2	6.9	6.9	9.7	4.3	3.2	5.0	2.5	22.2	32.5	5.5	5.7	31.6	4.8	4.5	14.5	5.1	4.9	4.0	5.3	22.8	4.9	3.3	3.9	6.4	7.4	6.5	8.4	6.6	12.0	6.2	7.0	6.5	8.3	6.3	6.2	8.1	4.7	8.7	8.4	11.9	38.0	25.9	15.5	11.0	19.3	16.8	58.6	14.7	27.3	27.9	23.6	277.8	18.3	23.8	6.9	15.5	112.0	0.0	76.5	152.3	23.7	78.5	13.9	306.5	146.5	11.1	56.1	41.1	109.5	7.7	22.7	46.5	25.3	53.3	85.9	26.7	42.8	52.6	27.6	74.2	45.5	12.9	12.2	7.7	30.8	13.0	80.0	16.0	106.9	38.2
IDH2		ENSG00000182054	"Isocitrate dehydrogenase (NADP(+)) 2, mitochondrial"	P48735	15	90083045-90102504	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 126.2;skeletal muscle: 190.7"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 682.3;Distal tubular cells: 989.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 69.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007831	Enhanced		Supported	Mitochondria		NA	NA		53000000	Mitochondria		"HPA007831: AB_1851397"	"unprognostic (2.45e-2)"	"prognostic favorable (5.15e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.53e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-2)"	5.4	2.0	14.9	10.1	16.6	22.6	8.8	4.9	19.1	6.4	16.2	13.8	12.4	16.1	5.9	15.3	23.7	6.0	9.4	126.2	10.2	9.3	25.0	93.2	6.9	15.8	14.4	12.0	3.0	25.1	8.4	3.3	15.1	11.9	13.3	14.5	6.0	28.0	21.9	190.7	11.0	13.9	15.8	11.0	7.5	27.9	1.2	7.6	28.2	3.4	69.0	13.6	11.0	8.6	16.8	32.8	17.2	56.3	22.2	29.5	31.2	10.3	5.9	30.6	30.3	4.3	5.2	26.0	13.0	19.8	12.3	13.2	2.8	9.0	12.3	3.7	10.7	11.7	3.6	4.4	3.9	5.8	24.2	2.9	21.0	2.2	20.6	5.2	14.4	21.3	11.0	2.2	2.9	2.3	14.9	25.1	43.6	3.1	10.6	9.4	30.2	69.1	22.4	9.1	14.2	2.4	58.6	21.9	36.7	18.9	12.5	44.1	22.4	16.1	64.4	5.2	17.8	51.9	44.5	6.0	21.9	3.2	2.8	6.0	17.5	3.2	1.4	7.0	30.3	12.6	9.0	26.4	17.2	26.1	48.0	12.4	16.8	18.7	29.5	32.8	9.8	10.2	18.2	5.1	22.2	56.3	17.8	15.9	31.2	14.9	16.6	4.9	19.1	10.2	9.3	14.4	12.0	11.9	7.6	6.0	21.8	67.0	66.5	35.4	5.3	402.1	104.4	56.2	21.6	71.5	9.8	682.3	989.8	188.2	4.7	25.3	53.5	23.3	255.6	386.0	36.6	189.5	30.1	240.4	229.9	9.5	59.3	41.1	60.4	2.5	13.0	70.5	55.6	96.4	122.1	17.5	127.7	132.1	33.2	128.5	5.1	12.9	38.3	0.5	4.5	58.6	479.2	123.2	268.2	90.1
NADK	FLJ13052	ENSG00000008130	"NAD kinase"	O95544	1	1751232-1780457	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 80.4"	"Group enriched"	"Detected in many"	7	"granulocytes: 80.4;monocytes: 24.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048909, HPA053368"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA048909: AB_2680553, HPA053368: AB_2682130"	"unprognostic (1.29e-1)"	"unprognostic (4.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.03e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.16e-1)"	24.7	34.3	11.1	19.0	11.9	49.0	25.5	9.9	12.6	12.4	18.2	10.8	14.1	20.3	13.9	14.5	12.5	14.3	17.1	11.9	9.9	7.9	12.7	52.3	17.5	27.0	15.8	8.6	16.9	32.2	8.3	11.9	22.5	10.3	13.7	14.1	13.9	21.4	14.5	10.6	11.7	19.4	14.4	8.3	39.4	22.1	17.3	9.6	10.8	14.0	12.0	19.2	13.7	28.3	1.8	7.2	80.4	24.7	0.5	1.4	10.4	15.1	14.6	13.1	19.2	18.7	13.6	16.9	15.3	13.4	17.5	15.6	15.6	27.9	20.1	11.7	11.3	5.6	12.9	14.0	12.1	7.8	19.5	22.3	16.4	22.9	26.9	18.1	23.0	27.6	15.9	11.0	10.8	15.5	9.5	16.9	16.0	20.1	28.8	13.0	17.3	17.3	20.0	8.9	25.5	16.5	22.0	11.2	41.1	15.1	12.6	17.7	13.5	17.1	37.7	15.7	8.1	12.9	16.1	16.3	12.8	9.2	13.1	13.7	25.7	11.6	45.0	12.6	25.5	6.6	11.8	21.1	49.5	1.2	24.7	1.4	1.8	0.7	0.9	7.2	1.7	0.5	0.7	80.4	0.5	23.8	5.9	1.0	10.4	11.1	11.9	9.9	12.6	9.9	7.9	15.8	8.6	10.3	9.6	11.9	30.7	29.2	12.9	8.8	7.3	5.6	28.1	9.4	18.2	14.0	15.7	22.0	13.3	18.5	13.2	18.0	35.4	23.3	25.3	21.4	15.7	25.2	2.3	80.8	33.4	6.4	21.9	14.7	54.6	20.0	34.8	30.2	8.5	40.5	34.0	5.1	24.7	33.1	32.5	18.2	15.9	12.9	17.0	10.8	20.5	11.2	35.8	13.8	26.2	19.2
NADK2	"C5orf33, FLJ30596, MNADK, NADKD1"	ENSG00000152620	"NAD kinase 2, mitochondrial"	Q4G0N4	5	36192592-36242279	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 128.6"	"Group enriched"	"Detected in many"	7	"Early spermatids: 231.1;Hepatocytes: 160.3;Late spermatids: 119.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038366, HPA038367, HPA061492"	Enhanced		Supported	Mitochondria		NA	NA		28000	Mitochondria		"HPA038366: AB_2675977, HPA038367: AB_10672743, HPA061492: AB_2684538"	"unprognostic (1.15e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.06e-3)"	"unprognostic (8.84e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.75e-2)"	5.7	10.2	13.7	4.1	12.5	4.4	6.8	6.7	13.4	6.6	6.0	13.3	5.9	7.0	5.9	4.1	4.9	6.0	5.5	8.3	14.3	8.5	10.0	128.6	4.0	4.2	11.6	12.0	8.8	12.2	4.8	3.1	7.2	11.6	9.5	6.2	3.9	5.6	7.7	11.1	3.3	5.5	24.8	20.3	3.8	7.6	7.3	11.4	2.5	7.6	3.5	5.1	15.2	5.9	5.1	3.3	9.1	4.2	9.5	3.2	1.7	9.1	6.0	9.2	10.5	14.1	12.0	12.6	8.6	5.7	7.9	5.9	16.8	11.5	32.9	6.4	9.8	9.8	6.4	8.6	6.3	11.1	9.1	7.6	8.8	17.8	9.8	10.4	19.1	3.5	13.2	9.7	8.7	13.2	9.8	8.3	12.8	23.2	11.8	7.9	3.6	17.8	7.3	5.1	7.4	8.7	17.3	22.8	7.0	10.1	7.8	4.1	9.3	44.4	14.1	4.6	7.6	10.0	16.8	6.2	15.4	8.4	11.6	10.2	10.8	13.0	9.7	6.5	24.9	6.0	9.1	2.0	1.9	2.1	2.0	2.7	2.2	3.2	2.5	3.3	5.1	2.7	2.2	0.1	9.5	4.2	1.5	2.9	1.7	13.7	12.5	6.7	11.4	14.3	8.5	11.6	12.0	11.6	11.4	3.0	5.8	6.7	5.9	6.1	5.5	25.5	22.9	8.1	7.9	5.2	7.9	6.8	21.6	3.9	231.1	6.8	5.2	0.0	8.0	6.9	11.2	12.7	1.1	160.3	7.5	3.2	6.9	13.5	8.9	119.7	18.4	4.9	13.5	2.8	11.7	15.3	8.4	7.0	21.5	19.6	5.0	0.0	13.0	16.7	10.5	5.0	6.1	5.7	12.3	8.1
NADSYN1	FLJ10631	ENSG00000172890	"NAD synthetase 1"	Q6IA69	11	71453109-71524107	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017798, HPA038523, HPA038524"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			Vesicles	"Golgi apparatus, Cytosol"	"CAB017798: , HPA038523: AB_2676060, HPA038524: AB_2676061"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.17e-6)"	"unprognostic (1.19e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (4.12e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (5.10e-4)"	14.5	16.9	10.8	23.2	21.2	39.6	14.0	12.2	18.5	12.4	30.6	21.9	24.1	26.3	15.0	17.5	29.1	16.4	33.1	10.6	10.4	9.5	16.5	24.8	18.1	20.5	22.7	9.2	15.6	20.6	13.5	20.2	17.1	15.6	23.9	25.3	12.9	18.0	17.2	9.8	15.0	36.8	13.6	14.6	30.7	19.2	17.4	20.0	26.4	17.3	21.7	29.8	26.1	17.1	9.5	22.3	12.8	19.7	11.9	12.6	13.1	6.1	14.9	4.8	8.8	14.6	21.4	13.3	12.0	10.9	6.3	6.9	12.7	10.5	5.4	13.7	14.1	8.4	22.1	6.3	17.2	3.3	10.9	5.1	8.8	10.0	14.1	18.3	17.6	17.0	30.3	27.1	8.1	7.4	14.4	22.1	9.8	4.5	7.6	8.9	19.3	8.6	11.5	2.9	27.5	8.7	10.8	15.3	5.3	15.5	28.6	3.6	5.2	8.6	11.3	22.0	7.6	10.0	9.6	26.6	7.0	6.0	12.7	4.6	9.8	4.2	4.6	12.3	10.1	4.8	4.5	19.7	11.8	11.7	17.4	9.9	9.5	10.5	10.6	22.3	7.4	7.0	8.8	12.8	11.9	15.1	16.7	12.6	13.1	10.8	21.2	12.2	18.5	10.4	9.5	22.7	9.2	15.6	20.0	20.8	35.4	18.2	14.5	5.6	6.5	6.9	15.3	14.7	18.2	10.4	3.9	14.5	3.3	15.1	16.8	15.8	63.6	23.3	14.9	11.8	10.8	15.4	20.9	14.4	17.4	12.7	22.5	9.2	22.1	49.9	8.6	20.8	8.5	20.8	28.6	6.9	16.9	54.7	9.6	13.9	7.7	12.9	7.8	16.4	4.3	11.2	14.4	21.3	38.6	20.2
NAMPT	"PBEF, PBEF1"	ENSG00000105835	"Nicotinamide phosphoribosyltransferase"	P43490	7	106248285-106286326	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Biological rhythms, Pyridine nucleotide biosynthesis"	"Cytokine, Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 597.4;Macrophages: 479.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	18	"neutrophil: 143.5"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 143.5"	"Cell line enhanced"	"Detected in all"		"U-87 MG: 110.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034349, HPA047776, HPA057722"	Approved		Approved	"Nuclear speckles,Cell Junctions"	"Secreted to blood"	NA	NA	2140000	410000	"Nuclear speckles"	"Cell Junctions"	"CAB034349: AB_2251220, HPA047776: AB_2680151, HPA057722: "	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (8.81e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (6.83e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.44e-3)"	67.3	22.2	8.1	113.6	18.1	110.4	52.6	7.8	12.9	11.6	18.2	2.9	9.5	9.3	9.9	13.5	53.4	27.8	28.1	84.4	13.4	6.3	13.5	92.9	48.9	117.5	10.3	5.2	27.3	18.3	5.5	10.0	23.9	29.2	17.4	10.5	8.2	32.9	14.3	41.0	12.9	14.1	44.9	59.1	41.1	26.4	11.9	7.1	6.2	13.5	40.7	13.2	48.8	26.4	0.8	2.0	143.5	7.3	1.0	1.5	1.3	19.2	12.9	4.6	7.8	19.7	23.0	7.6	6.1	34.6	12.4	21.9	7.6	11.7	16.1	14.7	6.8	37.2	15.2	8.6	18.4	27.2	9.5	9.2	6.5	5.5	5.9	73.7	12.6	12.1	21.9	21.1	22.2	26.0	18.6	39.5	8.0	13.6	62.0	14.8	10.1	12.6	5.3	9.0	12.2	10.4	6.0	6.6	35.5	11.8	18.2	9.5	5.2	8.6	18.8	21.8	13.4	6.0	3.6	33.6	18.5	14.3	26.5	11.2	42.7	24.2	23.3	110.0	14.3	27.4	8.1	2.3	3.5	0.4	5.6	0.7	0.8	0.5	0.6	2.0	0.7	0.8	0.4	143.5	1.0	7.3	0.8	1.5	1.3	8.1	18.1	7.8	12.9	13.4	6.3	10.3	5.2	29.2	7.1	122.1	246.8	48.1	258.1	184.4	22.1	87.9	163.1	104.4	177.5	40.1	11.8	23.8	39.7	250.8	6.3	173.0	92.2	0.0	120.5	44.2	117.9	276.9	178.5	597.4	98.8	38.1	24.1	141.8	340.8	4.5	37.4	479.6	153.5	65.9	46.4	19.5	161.8	35.1	29.4	36.0	28.4	25.8	234.9	14.9	57.9	181.7	21.2	41.5	63.9	273.8
NAPRT	"NAPRT1, PP3856"	ENSG00000147813	"Nicotinate phosphoribosyltransferase"	Q6XQN6	8	143574785-143578649	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Ligase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 22.3;SK-BR-3: 23.9;U-937: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023739, HPA024017, CAB068206, CAB068207"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		2000000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB068206: AB_2665644, CAB068207: AB_2665681, HPA023739: AB_1854308, HPA024017: AB_1854309"	"unprognostic (7.08e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.13e-2)"	"prognostic favorable (6.28e-4)"	"unprognostic (6.02e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.61e-2)"	9.7	6.4	4.9	9.7	6.2	21.1	13.2	10.7	5.4	6.7	25.2	2.3	9.9	33.0	4.7	4.7	16.4	4.8	15.5	4.9	3.9	2.1	10.7	28.3	8.3	12.1	3.7	0.1	5.9	6.5	2.4	2.8	8.6	4.1	6.9	3.8	5.2	12.8	3.8	7.1	12.4	34.4	5.2	2.2	9.8	11.8	5.5	4.0	3.0	6.8	8.9	9.5	7.6	8.1	0.8	4.7	4.6	8.4	0.5	1.6	2.4	3.4	4.0	0.4	0.8	0.3	1.2	2.6	0.8	0.4	1.3	0.8	3.3	22.3	0.9	6.3	0.2	0.0	7.7	0.2	6.3	0.0	4.1	6.4	5.3	10.5	0.9	2.8	1.3	2.8	0.1	2.2	0.1	0.0	0.0	1.4	4.4	4.9	4.1	0.1	4.3	2.6	2.7	1.0	4.7	2.5	4.6	0.1	11.0	0.9	1.3	1.8	0.4	10.0	23.9	3.0	0.1	0.9	3.1	4.2	0.7	6.4	4.7	1.7	0.5	0.2	1.1	1.1	18.5	3.3	0.0	4.4	4.6	1.6	8.4	0.5	0.8	0.7	1.5	4.7	0.2	0.8	0.7	2.7	0.5	8.4	1.5	0.2	2.4	4.9	6.2	10.7	5.4	3.9	2.1	3.7	0.1	4.1	4.0	32.8	29.7	8.2	53.6	0.0	11.6	7.8	50.9	2.7	17.0	71.5	17.7	41.1	58.0	56.8	30.9	28.6	149.9	23.3	48.4	46.0	12.4	35.0	7.0	99.2	70.9	15.9	10.5	37.4	86.2	46.4	29.7	44.6	0.0	92.0	73.3	27.1	82.3	117.4	20.5	160.6	12.5	12.9	11.5	15.6	17.6	0.0	47.0	17.5	111.6	67.7
NMNAT1	"LCA9, NMNAT, PNAT1"	ENSG00000173614	"Nicotinamide nucleotide adenylyltransferase 1"	Q9HAN9	1	9943428-9985501	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"	"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059447	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA059447: AB_2684022"	"unprognostic (1.94e-1)"	"unprognostic (3.81e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.45e-3)"	"unprognostic (4.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.57e-1)"	"prognostic favorable (3.85e-14)"	"unprognostic (3.11e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.16e-2)"	7.2	13.2	8.1	7.2	9.0	4.0	8.8	4.1	8.1	8.8	12.8	9.3	11.9	8.9	10.1	8.8	8.7	7.4	7.3	13.9	7.6	6.8	11.5	12.6	5.3	5.6	10.3	8.3	5.1	14.1	10.3	9.3	5.6	13.0	7.0	13.6	10.1	17.7	8.4	29.1	8.1	9.2	8.3	9.0	8.6	7.1	10.7	8.3	6.8	10.8	11.5	6.8	6.2	10.4	5.3	4.3	12.8	4.9	3.1	2.7	2.3	3.8	4.7	6.6	6.3	12.6	11.4	1.6	7.5	6.2	8.8	5.7	2.0	6.5	4.1	4.9	11.4	3.7	3.9	8.0	10.8	10.6	8.4	4.1	6.7	2.9	6.2	10.0	5.5	6.6	12.1	12.1	10.6	15.3	8.3	9.2	9.0	7.8	2.7	9.7	6.5	3.1	3.5	0.8	8.6	8.5	3.6	4.0	2.1	10.2	2.1	4.7	2.5	9.9	8.5	8.5	3.6	3.2	5.9	8.6	3.7	3.2	7.4	3.5	3.9	3.7	4.0	6.2	11.6	7.4	6.6	4.9	3.9	2.4	3.3	1.1	5.3	2.3	2.7	4.2	3.6	2.1	2.5	12.8	3.1	4.5	4.3	1.9	2.3	8.1	9.0	4.1	8.1	7.6	6.8	10.3	8.3	13.0	8.3	3.0	4.1	1.7	5.2	2.1	7.7	11.8	5.1	8.1	3.4	7.0	5.9	8.3	19.9	7.9	5.8	6.8	17.0	0.0	6.0	4.2	3.7	4.5	4.6	7.3	11.2	9.5	2.9	6.7	6.9	3.2	6.1	8.6	5.0	11.8	7.7	8.5	6.4	3.5	6.0	11.3	6.3	6.5	4.2	11.1	8.3	1.6	7.6	2.9	12.8	4.1
NMNAT2	"C1orf15, KIAA0479, PNAT2"	ENSG00000157064	"Nicotinamide nucleotide adenylyltransferase 2"	Q9BZQ4	1	183248237-183418602	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.9"	"Cell type enhanced"	"Detected in some"	14	"Cardiomyocytes: 30.1;Early spermatids: 50.3;Horizontal cells: 19.1;Late spermatids: 19.5;Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 12.9;SCLC-21H: 37.5;SuSa: 12.3;U-2197: 21.9;U-87 MG: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015708, HPA061714"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA015708: , HPA061714: AB_2732669"	"unprognostic (3.70e-1)"	"unprognostic (7.98e-3)"	"unprognostic (8.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (8.95e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.73e-3)"	"unprognostic (2.90e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.02e-1)"	9.6	7.7	26.2	1.9	34.5	1.0	2.9	53.9	53.5	3.6	2.2	2.0	0.0	1.5	2.5	2.7	1.9	3.8	4.1	19.6	20.6	15.1	1.5	1.1	1.8	1.7	8.6	28.3	1.5	2.9	1.3	17.4	2.0	15.6	1.3	2.1	0.5	1.5	4.1	1.3	1.7	2.0	2.7	4.1	1.2	2.1	8.7	6.3	0.0	7.2	0.0	1.7	1.9	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.2	2.5	0.0	1.5	6.2	2.2	1.6	4.1	0.8	0.2	1.2	2.4	0.0	6.8	0.4	0.7	1.0	0.1	0.0	1.6	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	12.9	0.5	1.0	0.2	5.3	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.2	4.4	0.0	2.4	0.0	0.1	0.0	2.8	2.0	37.5	2.9	0.3	0.1	0.0	12.3	0.3	0.6	1.4	1.2	0.4	21.9	1.5	0.3	0.0	0.0	17.1	0.1	0.1	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	26.2	34.5	53.9	34.7	20.6	15.1	8.6	28.3	15.6	6.3	0.0	1.0	0.0	0.2	0.7	10.7	30.1	0.0	2.7	3.4	0.0	0.0	0.6	0.0	0.1	50.3	2.9	0.0	0.0	0.0	9.6	0.4	0.1	0.0	0.0	0.5	19.1	0.0	0.0	0.6	19.5	0.0	0.5	1.7	0.0	0.0	0.3	0.5	0.0	0.0	0.0	1.6	19.4	5.0	0.5	0.2	0.3	1.1	0.0	0.0	0.0
NMNAT3	PNAT3	ENSG00000163864	"Nicotinamide nucleotide adenylyltransferase 3"	Q96T66	3	139560180-139678017	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 527.0;Alveolar cells type 2: 437.0;Ciliated cells: 459.0;Club cells: 396.9;granulocytes: 256.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039077, HPA057402"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA039077: AB_2676336, HPA057402: AB_2683427"	"unprognostic (9.45e-3)"	"prognostic favorable (9.67e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.77e-3)"	"unprognostic (6.22e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.92e-1)"	"prognostic favorable (7.29e-5)"	"unprognostic (4.57e-2)"	"prognostic favorable (1.95e-5)"	"unprognostic (4.13e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.07e-1)"	6.2	6.3	9.9	7.0	9.8	14.1	10.8	7.7	9.8	7.4	7.4	6.8	2.7	7.8	7.9	7.3	6.5	11.6	7.9	12.6	11.9	8.1	7.9	6.2	4.7	3.6	7.7	14.0	17.9	10.0	6.2	6.6	1.8	6.7	7.6	6.4	12.7	7.5	4.8	21.9	14.9	6.5	7.3	7.0	4.2	4.8	16.8	8.4	2.4	8.3	9.0	4.8	6.3	6.8	7.2	4.2	11.9	5.0	6.1	5.1	2.1	6.8	3.0	3.3	3.7	0.8	0.7	4.4	2.9	0.4	0.5	0.4	3.9	5.2	4.8	8.8	0.6	3.3	3.5	2.3	1.0	0.7	4.4	3.9	22.3	6.3	5.0	1.8	4.2	4.3	1.2	5.8	0.9	1.4	7.0	0.5	2.9	3.9	10.6	0.5	4.7	4.0	3.7	7.5	12.0	2.9	3.5	3.7	3.2	1.0	5.2	7.2	4.4	6.9	3.8	2.5	6.5	9.5	11.2	3.9	4.7	10.4	5.6	4.3	17.6	8.3	3.4	3.2	6.7	4.3	11.9	5.0	3.0	4.1	4.5	3.0	3.6	3.6	3.4	3.6	7.2	5.1	5.1	10.8	6.1	4.4	4.2	2.2	2.1	9.9	9.8	7.7	9.8	11.9	8.1	7.7	14.0	6.7	8.4	527.0	437.0	3.0	5.2	3.7	2.5	7.5	2.5	459.0	396.9	8.7	3.9	0.3	10.0	2.6	101.2	2.3	2.0	0.0	2.7	0.3	4.7	3.7	256.9	2.1	1.9	1.6	6.4	3.1	2.6	164.7	7.2	4.0	6.8	0.0	5.5	7.8	0.7	3.5	6.0	12.0	18.2	6.5	1.2	39.2	2.6	8.4	0.1	0.0	11.4	3.8
NMRK1	"bA235O14.2, C9orf95, FLJ20559, NRK1"	ENSG00000106733	"Nicotinamide riboside kinase 1"	Q9NWW6	9	75060573-75088217	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 102.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 29.9;Karpas-707: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049795	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Centrosome	"HPA049795: AB_2680886"	"unprognostic (1.12e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.58e-2)"	"prognostic favorable (3.70e-6)"	"unprognostic (3.56e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.20e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (5.60e-4)"	"unprognostic (9.25e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.64e-2)"	15.5	7.7	11.1	15.9	10.7	6.9	14.3	21.5	14.6	13.2	15.2	5.8	20.1	12.2	8.1	15.6	24.6	9.4	10.9	9.4	10.2	9.7	22.1	40.3	15.4	19.9	10.8	9.7	15.2	30.6	45.8	18.1	19.7	10.2	15.9	10.3	10.9	29.5	17.7	15.0	15.6	26.6	8.3	8.7	18.8	13.6	6.7	8.9	14.4	31.6	11.2	22.0	12.6	14.8	6.7	8.8	7.3	6.7	8.2	24.2	10.1	5.1	1.1	1.5	3.5	12.2	16.5	8.3	7.5	11.8	1.9	3.1	0.0	13.6	3.0	4.5	7.2	3.6	9.0	1.7	5.0	6.0	29.9	1.8	2.1	2.4	2.6	10.9	2.0	0.4	11.4	12.9	3.1	6.4	11.4	13.0	5.2	0.2	36.8	13.2	3.8	1.9	1.8	1.9	19.4	4.7	0.6	13.5	19.3	15.3	9.2	1.0	0.2	3.2	3.3	4.2	10.3	8.5	2.2	8.9	6.5	1.2	5.9	2.0	16.3	13.0	1.8	10.6	2.2	6.6	7.3	2.7	4.5	13.9	2.5	16.7	6.7	24.2	16.0	3.1	3.9	22.1	16.7	5.2	8.2	6.7	8.8	15.4	10.1	11.1	10.7	21.5	14.6	10.2	9.7	10.8	9.7	10.2	8.9	35.7	17.1	17.1	33.3	18.7	8.5	15.1	15.3	20.1	22.7	22.7	7.9	52.7	44.7	25.5	14.0	20.7	33.3	0.0	31.3	65.3	17.5	21.3	1.1	34.4	51.6	11.1	4.1	39.3	19.7	24.5	21.9	10.5	25.3	102.8	28.0	9.6	23.2	24.6	11.7	75.6	7.6	12.9	15.2	6.6	3.8	23.6	38.1	29.9	22.4	26.0
NMRK2	"ITGB1BP3, MIBP, NRK2"	ENSG00000077009	"Nicotinamide riboside kinase 2"	Q9NPI5	19	3933103-3942416	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"heart muscle: 271.6;skeletal muscle: 103.2"	"Cell type enriched"	"Detected in single"	1346	"Cardiomyocytes: 751.9"	"Cancer enhanced"	"Detected in some"		"renal cancer: 32.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 22.8;NTERA-2: 18.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049909, HPA054792, HPA072450"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA049909: , HPA054792: AB_2682601, HPA072450: AB_2686522"				"unprognostic (3.61e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.18e-2)"		"unprognostic (2.54e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.61e-2)"		"unprognostic (3.30e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.38e-1)"		0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	1.0	0.0	0.0	271.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	1.0	1.9	0.1	103.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	18.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	751.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
NNMT		ENSG00000166741	"Nicotinamide N-methyltransferase"	P40261	11	114257787-114313285	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 97.7"	"Cell type enriched"	"Detected in many"	9	"Hepatocytes: 3284.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 68.8;LHCN-M2: 40.9;RPTEC TERT1: 105.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059180	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		15000	"Golgi apparatus"	Cytosol	"HPA059180: AB_2683940"	"unprognostic (1.62e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (1.76e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-6)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-3)"	"unprognostic (2.77e-2)"	23.7	1.4	0.6	8.8	0.9	0.1	14.6	0.6	1.7	13.1	8.5	0.7	4.9	0.5	15.8	8.7	12.0	8.3	15.3	8.2	1.6	0.0	4.7	97.7	10.0	3.4	1.1	0.6	11.2	2.0	0.6	2.6	8.6	3.3	9.6	3.3	1.6	3.6	6.7	18.3	8.2	4.3	12.4	1.5	5.8	5.1	7.3	0.6	1.3	5.3	2.2	3.1	10.9	35.3	0.6	0.1	0.7	0.2	0.0	0.9	0.0	0.0	4.8	0.0	4.3	24.8	32.2	0.0	6.1	16.3	9.8	19.5	0.0	6.6	0.0	21.8	12.5	1.3	0.0	0.0	2.2	9.9	0.0	0.0	0.0	7.6	0.0	33.8	0.0	0.0	68.8	23.8	6.9	10.3	8.2	13.5	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	27.4	0.0	105.9	0.0	0.0	0.0	30.7	0.0	0.0	1.5	0.0	0.0	9.5	5.6	22.6	8.7	1.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.2	0.0	0.2	0.1	0.9	0.2	0.0	0.2	0.1	0.6	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.6	0.9	0.6	1.7	1.6	0.0	1.1	0.6	3.3	0.6	41.7	380.8	30.2	10.6	92.0	0.5	4.0	76.5	18.7	20.5	76.8	0.0	0.9	8.3	207.6	0.2	191.1	0.0	163.5	133.3	1.9	375.3	11.6	12.8	3284.1	21.8	0.0	5.1	176.1	103.2	1.0	68.7	12.7	91.1	10.0	0.0	0.0	366.0	0.0	12.4	27.9	0.1	0.0	113.1	0.3	0.4	80.5	1.8	46.0	0.0	2.4
NT5C	"cdN, DNT-1, DNT1, PN-I, UMPH2"	ENSG00000125458	"5', 3'-nucleotidase, cytosolic"	Q8TCD5	17	75130225-75131795	"Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021581, HPA023632"	Approved		Supported	Cytosol		NA	NA		600000	Cytosol		"HPA021581: AB_1854663, HPA023632: AB_1854662"	"unprognostic (3.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.26e-1)"	"unprognostic (7.25e-2)"	"unprognostic (8.26e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.13e-1)"	"prognostic favorable (7.66e-4)"	14.5	16.7	10.7	32.5	10.5	14.4	15.2	16.0	13.8	16.3	27.3	18.5	16.2	25.1	18.0	18.7	21.6	15.9	21.0	16.7	9.6	11.0	21.0	13.5	19.9	30.1	12.3	11.0	19.7	28.0	10.4	9.7	11.6	10.9	17.5	14.2	18.0	17.9	17.7	27.1	16.0	30.1	16.7	13.7	20.5	24.5	11.4	12.0	17.2	22.0	30.4	24.5	20.5	17.1	30.7	16.8	46.7	15.8	22.7	14.3	9.7	21.0	33.1	10.9	11.4	3.3	6.9	15.0	12.6	11.0	12.7	8.1	12.3	24.9	14.7	9.2	8.8	2.3	14.8	7.6	15.7	7.3	6.9	23.9	16.1	25.7	20.6	16.5	15.6	7.4	10.0	7.5	9.1	25.5	5.2	14.1	11.7	15.7	7.2	13.0	21.2	11.4	15.9	11.2	18.3	22.0	10.4	14.3	20.4	16.5	11.4	12.9	26.5	12.1	15.0	17.4	6.5	21.0	11.5	8.1	11.1	27.5	4.2	16.6	14.3	2.1	16.3	10.3	9.6	17.2	46.7	10.2	15.2	13.8	15.8	9.7	30.7	9.0	11.6	12.7	29.1	7.9	11.9	4.6	22.7	15.5	16.8	14.3	9.7	10.7	10.5	16.0	13.8	9.6	11.0	12.3	11.0	10.9	12.0	29.8	21.6	121.5	83.2	42.1	67.1	15.5	94.3	9.4	11.4	55.8	19.6	58.2	66.3	80.9	1.6	21.2	215.1	0.0	106.1	86.7	57.7	61.8	46.1	34.2	66.0	39.7	61.5	16.5	50.0	3.3	55.0	59.6	55.6	144.3	82.5	46.3	97.1	133.3	44.6	119.5	63.7	32.3	67.0	20.7	54.1	38.8	26.1	67.1	96.4	63.4
NT5C1A	"CN-I, CN-IA, CN1, CN1A, MGC119199, MGC119201"	ENSG00000116981	"5'-nucleotidase, cytosolic IA"	Q9BXI3	1	39659121-39672038	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 51.9;tongue: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"SH-SY5Y: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA050283, HPA054158"	Supported					NA	NA					"HPA050283: AB_2681072, HPA054158: AB_2682402"	"unprognostic (7.85e-2)"				"unprognostic (1.60e-1)"	"unprognostic (6.19e-1)"		"unprognostic (1.51e-3)"	"unprognostic (7.19e-2)"		"unprognostic (2.87e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-2)"		"unprognostic (1.81e-2)"		0.7	2.8	1.2	0.8	3.0	0.5	0.5	5.6	7.6	0.7	0.5	1.0	0.0	0.5	0.6	2.9	3.0	0.7	0.5	9.8	1.7	1.7	0.9	0.5	0.5	0.5	1.8	4.9	0.7	6.0	0.5	0.5	0.5	6.9	0.9	0.5	0.0	0.7	0.7	51.9	0.5	0.6	0.6	5.2	0.5	0.6	0.7	1.0	0.0	0.5	13.9	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	20.4	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.0	5.6	7.6	1.7	1.7	1.8	4.9	6.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NT5C1B	"AIRP, CN-IB"	ENSG00000185013	"5'-nucleotidase, cytosolic IB"	Q96P26	2	18562872-18589572	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 52.6"	"Group enriched"	"Detected in some"	90	"Early spermatids: 137.7;Late spermatids: 218.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA056683	Uncertain					NA	NA					"HPA056683: AB_2683207"	"unprognostic (4.18e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.84e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.77e-1)"	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.3	0.7	0.0	0.4	0.3	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.5	52.6	0.1	0.1	0.5	0.1	0.1	0.5	0.1	1.2	3.7	0.0	0.1	0.7	2.6	0.4	3.2	0.7	0.3	0.0	0.0	0.0	0.5	2.5	0.0	0.0	0.0	0.0	3.5	1.6	0.5	0.0	2.2	1.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.9	0.0	0.6	0.1	0.0	0.0	0.2	0.0	3.3	0.0	0.5	1.1	0.2	0.0	2.9	0.1	0.2	0.6	0.6	1.6	0.3	0.7	0.8	0.1	2.9	2.4	1.2	2.6	0.4	1.5	0.4	0.7	0.7	1.6	1.5	1.0	2.9	0.5	1.0	0.7	2.0	2.5	0.0	1.2	0.0	0.1	0.0	1.3	0.0	2.3	0.1	1.3	1.3	0.3	1.2	2.6	2.2	0.0	0.7	0.1	3.7	0.5	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	137.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	218.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.6	1.2	0.0	0.0	0.0	0.0	0.0
NT5C1B-RDH14		ENSG00000250741	"NT5C1B-RDH14 readthrough"		2	18555545-18589564	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	74	"testis: 49.4"	"Group enriched"	"Detected in some"	76	"Early spermatids: 43.1;Late spermatids: 43.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"TIME: 1.1"									HPA056683	Uncertain					NA	NA					"HPA056683: AB_2683207"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0
NT5C2	"cN-II, GMP, NT5B, PNT5, SPG65"	ENSG00000076685	"5'-nucleotidase, cytosolic II"	P49902	10	103088017-103193306	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Allosteric enzyme, Hydrolase"	"Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003751	Approved					NA	NA					"HPA003751: AB_1854664"	"unprognostic (8.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.41e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.50e-1)"	15.0	17.0	17.6	18.2	21.2	31.6	19.7	22.5	19.6	17.5	20.7	25.4	24.5	10.9	24.6	19.6	38.6	14.8	17.0	16.5	16.7	20.7	19.6	15.5	18.8	16.8	21.8	17.3	24.8	19.4	18.7	29.5	16.9	29.1	22.9	17.0	26.2	67.2	21.6	41.6	11.7	13.9	20.4	19.1	20.5	15.9	21.7	14.5	29.7	39.2	16.3	31.5	21.1	31.1	6.7	9.7	23.8	14.5	10.5	8.7	7.1	50.7	20.7	14.4	32.3	12.7	14.1	8.3	25.5	24.8	12.4	12.9	15.0	40.7	24.3	19.8	17.6	10.8	26.0	9.5	13.1	14.6	14.6	8.9	17.5	8.8	14.5	22.7	25.3	8.7	21.7	14.6	10.8	17.5	30.2	11.4	11.8	11.3	17.0	21.5	30.0	22.6	32.8	13.6	15.5	25.6	36.9	12.4	7.0	17.8	29.0	4.3	10.8	13.4	10.6	20.0	20.4	16.1	19.7	11.6	9.9	10.0	14.1	18.6	14.9	24.7	32.6	10.0	29.3	2.8	19.8	11.7	23.8	8.1	11.9	8.7	6.7	7.0	6.5	9.7	4.2	6.0	6.2	21.4	10.5	14.5	7.3	6.5	7.1	17.6	21.2	22.5	18.0	16.7	20.7	21.8	17.3	29.1	14.5	77.4	27.5	10.4	26.3	6.5	19.9	2.4	20.4	32.1	67.1	26.2	43.2	16.3	10.0	27.7	82.0	15.7	21.6	0.0	22.4	10.0	11.0	32.1	8.1	14.9	17.8	44.5	11.1	12.3	30.0	49.8	23.0	20.7	25.3	13.6	16.7	78.8	41.7	14.2	12.7	13.9	53.0	32.3	12.6	23.0	21.5	6.6	29.3	16.6	13.3	73.2
NT5C3A	"cN-III, hUMP1, NT5C3, p36, P5'N-1, PN-I, POMP, PSN1, UMPH, UMPH1"	ENSG00000122643	"5'-nucleotidase, cytosolic IIIA"	Q9H0P0	7	33014113-33062797	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA010630, HPA029058"	Uncertain				"Intracellular and membrane"	NA	NA					"HPA010630: AB_2668319, HPA029058: AB_10601380"	"unprognostic (7.50e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (9.37e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.43e-3)"	12.3	12.1	9.9	17.0	9.9	15.4	11.4	16.2	12.2	12.0	27.5	7.4	8.1	20.9	14.7	11.6	12.0	9.0	12.9	11.6	9.8	10.3	11.7	10.5	11.6	15.0	10.3	9.8	10.3	19.1	5.5	10.9	10.6	8.4	9.6	27.2	8.5	9.0	8.9	53.3	15.0	19.7	7.5	9.9	18.4	14.5	6.3	8.9	15.4	9.8	28.8	22.8	12.0	11.6	21.4	6.8	36.6	11.4	8.6	18.9	13.3	14.3	10.5	9.8	8.7	7.4	6.5	7.9	15.7	10.3	10.7	14.6	6.5	40.6	36.1	9.1	9.2	18.7	21.9	10.5	10.4	15.9	5.6	13.5	16.4	12.4	9.4	7.9	19.5	13.6	7.2	9.3	11.7	23.5	6.5	7.0	12.4	14.1	9.6	13.2	9.8	7.2	30.6	10.0	17.3	9.2	9.6	8.9	21.3	34.1	15.1	10.5	13.1	10.3	19.4	24.6	8.6	12.9	10.9	6.1	9.1	8.2	15.5	20.5	19.3	22.0	17.7	7.5	12.1	14.2	26.9	8.0	29.8	9.0	10.2	10.2	21.4	12.1	11.0	6.8	20.5	12.4	10.6	36.6	8.6	11.4	6.4	18.9	13.3	9.9	9.9	16.2	12.2	9.8	10.3	10.3	9.8	8.4	8.9	20.8	10.7	82.5	30.5	41.6	22.0	14.0	30.6	37.5	27.3	15.7	39.3	30.8	24.9	25.8	3.2	34.9	102.1	46.7	70.0	25.2	31.9	27.6	17.3	16.3	22.9	1.6	114.8	20.3	26.5	3.6	31.4	25.2	25.3	17.2	74.0	23.6	44.1	98.2	20.8	48.5	23.5	12.9	27.8	30.9	17.2	34.0	23.7	34.5	50.5	60.6
NT5C3B	"cN-IIIB, MGC20781, NT5C3L"	ENSG00000141698	"5'-nucleotidase, cytosolic IIIB"	Q969T7	17	41825181-41836263	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 135.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030786, HPA057095"	Approved					NA	NA					"HPA030786: AB_10602716, HPA057095: AB_2683333"	"unprognostic (3.90e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (8.11e-5)"	"unprognostic (3.40e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.07e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.36e-2)"	"unprognostic (4.80e-3)"	"unprognostic (7.14e-3)"	"unprognostic (1.42e-2)"	10.0	12.4	15.9	8.3	26.2	3.2	18.3	22.8	31.2	11.6	15.6	8.4	10.1	4.4	14.1	21.3	13.9	12.6	11.5	11.4	15.0	14.9	19.2	19.4	11.0	7.9	12.9	16.4	15.5	19.6	21.1	13.7	11.5	13.2	12.6	13.8	12.6	15.9	20.1	7.8	8.6	8.1	22.1	6.7	7.7	12.0	24.8	9.8	1.4	37.8	5.6	10.7	13.3	9.7	5.3	5.2	2.5	5.6	1.0	5.9	4.1	8.6	13.0	22.2	29.2	20.4	17.3	3.1	8.7	25.4	27.8	27.8	10.6	5.1	13.0	4.5	17.8	17.4	8.4	22.0	12.3	45.2	6.4	8.7	7.9	13.5	11.2	13.6	0.1	3.3	12.2	11.8	23.5	19.2	20.9	16.1	10.4	7.3	8.1	19.6	5.1	12.6	3.0	5.9	17.2	1.9	10.8	29.6	12.0	12.1	9.4	13.6	7.0	13.1	47.0	4.6	28.9	12.7	4.7	11.0	8.6	6.7	14.3	17.9	1.6	6.6	6.3	11.2	0.2	10.5	1.5	5.6	0.5	3.8	1.0	5.8	4.7	5.9	5.1	5.2	5.3	5.4	4.5	2.5	1.0	0.7	2.7	0.8	4.1	15.9	26.2	22.8	31.2	15.0	14.9	12.9	16.4	13.2	9.8	8.9	15.0	15.7	49.4	16.1	30.4	11.2	7.6	14.7	7.9	27.9	17.7	35.2	86.2	47.9	69.9	21.5	2.5	0.0	36.0	48.9	37.1	35.6	11.5	19.7	11.9	109.7	37.8	19.0	7.9	92.8	30.0	17.0	33.7	5.4	12.5	29.9	37.1	12.9	28.7	45.0	27.3	38.8	52.0	135.0	29.1	15.1	26.1	13.8	14.0	38.3
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ito cells: 45.4;Pancreatic endocrine cells: 72.9;Rod photoreceptor cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 13.4;memory CD8 T-cell: 6.6;naive B-cell: 19.9;naive CD8 T-cell: 17.3"	"Group enriched"	"Detected in many"	47	"B-cells: 19.9;T-cells: 17.3"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 93.4;LHCN-M2: 105.7;TIME: 61.2;U-87 MG: 95.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1600000	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	12.2	3.2	9.3	7.7	11.6	0.5	16.6	1.1	6.9	58.8	13.9	3.6	8.1	18.6	33.3	14.8	7.6	12.2	15.4	6.1	5.7	5.5	8.8	26.0	3.4	6.8	6.3	6.6	25.4	1.4	1.6	9.3	42.2	5.3	16.4	15.6	15.3	4.6	17.8	5.7	4.5	14.9	35.3	6.3	7.0	6.0	12.4	4.2	1.6	26.5	7.3	7.1	16.6	20.2	19.9	0.0	0.2	0.0	0.4	17.3	3.9	5.3	2.8	4.9	0.1	11.2	35.7	0.0	34.5	37.8	17.0	32.0	0.0	53.0	0.0	12.4	30.1	43.8	2.7	0.0	34.7	40.6	0.0	0.0	0.0	0.8	0.6	5.6	0.0	0.0	9.1	0.4	34.7	22.1	93.4	14.1	0.0	0.0	0.1	105.7	0.9	0.0	0.0	0.1	0.9	3.8	0.1	1.1	0.1	36.8	2.4	0.0	0.6	0.4	2.1	11.7	0.2	0.0	0.9	61.2	13.9	0.1	17.5	56.1	2.6	1.6	0.0	95.4	0.0	43.5	0.0	0.0	0.2	2.0	0.0	3.5	13.4	2.3	6.6	0.0	19.9	2.4	17.3	0.2	0.4	0.0	0.0	0.8	3.9	9.3	11.6	1.1	6.9	5.7	5.5	6.3	6.6	5.3	4.2	0.0	4.3	15.6	1.0	4.6	4.6	0.8	20.4	6.7	6.8	1.8	9.8	0.4	3.3	3.7	0.5	13.5	10.3	0.0	3.7	1.5	16.9	0.9	0.0	29.0	1.3	0.0	0.0	45.4	5.3	0.9	12.0	2.5	6.8	0.0	33.2	5.6	72.9	31.7	24.1	20.6	77.4	0.0	8.0	0.0	0.2	4.3	12.7	2.2	13.8	5.9
NT5M	"dNT-2, dNT2, mdN"	ENSG00000205309	"5',3'-nucleotidase, mitochondrial"	Q9NPB1	17	17303335-17347663	"Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 27.1"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 14.9;Erythroid cells: 23.3;Horizontal cells: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"JURKAT: 10.1;U-266/70: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043777	Uncertain					NA	NA					"HPA043777: AB_10962842"	"unprognostic (5.70e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.59e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (8.42e-5)"	"unprognostic (4.28e-5)"	"unprognostic (2.27e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.05e-2)"	2.6	1.8	7.2	2.0	7.4	9.4	2.1	8.8	11.8	3.3	2.8	3.7	3.1	2.1	2.8	1.9	2.7	3.0	1.9	6.6	5.8	5.3	3.3	5.5	1.7	1.7	5.5	3.9	3.8	1.9	2.9	5.0	1.5	5.7	3.3	1.4	3.5	2.7	2.7	27.1	2.1	2.2	2.0	4.1	1.7	1.3	7.0	2.0	4.2	1.7	2.4	1.6	2.6	1.7	0.2	0.6	3.6	0.0	0.0	1.5	3.1	0.4	0.9	0.4	3.5	2.2	2.4	1.6	0.7	0.2	0.3	0.5	0.0	0.2	4.0	2.1	0.0	0.7	0.0	0.2	0.1	0.0	3.4	2.2	2.6	0.0	0.3	2.1	0.7	5.2	1.7	1.8	0.3	1.4	0.7	0.1	10.1	2.2	0.0	0.0	1.0	3.3	2.9	2.2	1.1	3.1	2.5	0.3	7.1	1.2	0.0	4.4	6.8	1.2	0.2	3.1	2.7	1.2	1.0	0.0	1.1	1.3	0.3	0.9	11.1	1.4	0.6	0.6	0.5	2.8	0.0	0.0	3.6	0.1	0.0	1.4	0.0	0.1	1.5	0.6	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	3.1	7.2	7.4	8.8	11.8	5.8	5.3	5.5	3.9	5.7	2.0	0.0	0.3	0.0	1.7	1.4	5.8	7.2	0.0	0.0	1.2	8.7	2.0	0.5	14.9	0.2	0.8	0.8	0.0	23.3	0.5	0.9	1.0	1.2	0.0	1.0	1.2	15.9	1.2	0.6	0.3	3.6	0.6	0.5	0.0	0.0	0.6	3.5	0.0	0.0	1.1	1.7	1.5	0.0	0.9	0.9	4.1	0.4	0.5	0.9	0.2	0.4
NUDT12	DKFZP761I172	ENSG00000112874	"Nudix hydrolase 12"	Q9BQG2	5	103548855-103562793	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045449	Supported					NA	NA					"HPA045449: AB_2679327"	"unprognostic (1.94e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.79e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.86e-5)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.92e-2)"	6.3	15.2	10.1	3.5	13.3	0.9	11.4	6.1	12.5	9.2	11.9	10.2	10.9	15.3	6.1	11.7	10.1	8.1	7.7	9.2	10.0	8.9	24.7	25.3	6.1	2.4	13.1	8.5	6.6	15.3	26.9	14.7	6.8	13.7	13.9	13.4	8.4	11.2	7.9	12.1	8.2	15.8	8.7	14.8	4.3	12.5	5.9	14.8	5.0	15.0	8.7	3.4	8.9	6.0	1.5	3.9	0.0	1.3	1.5	2.2	0.9	4.0	1.8	10.1	3.8	6.9	14.5	0.0	7.2	6.9	6.6	8.5	3.5	14.9	0.0	4.8	4.1	7.3	6.7	9.4	15.0	9.2	0.0	5.7	4.2	7.1	1.8	7.1	0.0	0.0	6.9	13.2	4.4	11.4	7.7	4.4	0.0	6.8	0.0	11.4	7.5	0.3	0.2	5.1	0.0	5.7	0.0	8.9	3.3	11.1	7.1	7.6	7.9	4.7	7.0	11.0	8.3	15.4	4.2	5.4	8.3	3.0	7.2	5.7	4.9	7.5	0.0	8.5	0.0	6.0	0.0	0.9	0.0	0.0	1.3	0.0	0.9	0.8	0.5	2.8	1.5	2.2	1.0	0.0	1.5	0.9	3.9	0.6	0.9	10.1	13.3	6.1	12.5	10.0	8.9	13.1	8.5	13.7	14.8	8.9	7.0	2.4	5.1	3.0	9.0	11.2	15.3	14.7	4.5	12.2	2.0	4.9	49.7	8.9	4.2	2.9	16.5	0.0	12.2	3.1	3.4	8.4	1.1	12.9	5.2	11.1	4.1	1.8	4.1	3.4	12.4	4.3	8.5	2.8	14.0	12.9	10.2	12.4	9.9	27.0	14.6	6.5	5.8	11.1	4.4	2.8	2.5	0.0	11.6	7.0
PNP	"NP, PUNP"	ENSG00000198805	"Purine nucleoside phosphorylase"	P00491	14	20468954-20477094	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 153.1"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 276.6;Syncytiotrophoblasts: 540.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 82.7;U-937: 94.3"					"Low region specificity"	"Detected in all"			HPA001625	Enhanced		Supported	Cytosol		NA	NA		100000000	Cytosol		"HPA001625: AB_1854577"	"unprognostic (1.20e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (4.94e-3)"	"unprognostic (3.87e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (1.69e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	24.7	7.6	9.5	15.0	14.0	69.4	15.7	13.9	11.8	9.5	19.1	6.2	25.2	29.4	5.9	153.1	34.0	7.8	15.7	12.1	11.5	8.4	49.7	24.2	18.3	13.2	13.5	3.4	3.6	11.0	8.7	8.4	45.3	17.7	6.0	16.1	3.8	9.2	7.9	3.3	10.6	32.0	9.8	16.3	18.0	17.0	4.5	12.5	7.0	7.1	21.7	19.1	7.5	14.7	13.1	20.7	4.1	12.4	15.7	33.7	12.1	13.4	18.2	3.8	8.7	4.4	3.5	11.9	13.8	6.5	11.3	11.1	10.5	12.3	36.0	16.0	7.3	13.3	14.6	20.4	26.0	15.0	11.6	17.9	30.1	15.5	17.3	4.1	82.7	15.7	2.4	9.4	34.0	15.1	6.2	48.1	22.3	14.8	22.5	14.1	12.5	24.3	48.8	11.0	34.4	30.4	20.6	5.8	14.0	40.1	12.8	16.9	3.7	26.5	33.7	2.1	5.6	12.4	14.7	38.5	7.7	10.3	17.3	23.4	10.3	17.2	40.7	6.6	94.3	0.7	4.0	12.4	4.1	18.1	11.5	33.7	11.2	20.3	20.0	20.7	13.1	12.9	16.3	1.6	15.7	10.6	11.7	6.9	12.1	9.5	14.0	13.9	11.8	11.5	8.4	13.5	3.4	17.7	12.5	0.0	26.3	18.6	51.4	75.2	4.8	3.1	28.1	8.1	17.0	78.5	13.7	276.6	33.2	38.4	1.0	60.2	56.3	93.5	44.5	26.6	19.4	21.8	56.6	23.1	63.4	15.9	44.5	19.6	22.4	0.0	0.3	46.2	28.7	1.0	31.7	70.2	85.7	56.1	0.7	91.5	17.0	0.0	33.8	0.2	0.6	55.8	540.4	19.3	34.8	70.5
PXYLP1	"ACPL2, FLJ23751"	ENSG00000155893	"2-phosphoxylose phosphatase 1"	Q8TE99	3	141228726-141367753	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 89.2"	"Cell type enhanced"	"Detected in many"	16	"Collecting duct cells: 43.6;Early spermatids: 163.2;Late spermatids: 68.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017243	Uncertain				"Intracellular and membrane"	NA	NA					"HPA017243: AB_1844509"	"unprognostic (9.55e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.45e-2)"	"unprognostic (8.04e-3)"	"unprognostic (4.05e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.07e-3)"	"unprognostic (4.67e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.56e-2)"	"unprognostic (8.17e-3)"	4.1	4.4	9.1	3.8	11.8	3.2	5.5	3.8	13.2	6.5	3.7	5.9	23.7	3.8	8.6	89.2	2.2	5.8	5.4	8.9	6.6	6.6	5.1	3.5	4.9	9.0	4.5	7.4	6.5	8.6	8.6	6.5	10.8	5.2	6.7	4.0	5.2	5.1	20.7	3.3	4.2	4.7	4.8	5.4	3.8	5.5	13.7	4.6	28.0	4.3	1.9	6.1	6.0	4.5	0.5	3.8	7.2	4.1	13.0	16.8	6.3	3.4	3.6	15.6	12.3	6.2	5.4	3.7	2.3	5.9	6.1	8.5	6.0	1.2	0.2	3.3	5.4	1.3	0.8	16.4	1.5	5.9	11.1	10.8	1.2	4.9	4.7	13.2	3.0	0.6	5.0	7.0	1.8	0.6	7.7	0.4	11.8	0.5	1.4	2.8	2.9	16.3	3.9	6.5	8.5	2.0	2.3	9.1	2.1	4.3	14.9	6.8	12.1	6.1	1.9	5.0	3.0	6.5	1.8	0.7	7.9	4.7	5.3	2.2	3.3	0.2	0.5	7.3	4.2	6.9	7.2	4.1	6.2	9.9	2.8	6.4	0.5	5.7	6.6	3.8	0.4	16.8	13.5	2.8	13.0	1.3	1.3	3.0	6.3	9.1	11.8	3.8	13.2	6.6	6.6	4.5	7.4	5.2	4.6	8.9	8.3	0.8	3.8	0.0	2.2	6.7	2.5	5.3	3.4	43.6	5.9	1.6	0.0	3.0	163.2	1.5	2.6	0.0	3.3	5.9	3.1	6.0	2.3	3.0	0.6	6.4	4.1	0.6	1.9	68.3	18.7	1.4	0.0	2.8	2.2	6.0	3.3	8.6	14.2	9.5	5.4	12.9	1.7	31.9	9.4	0.0	0.9	2.5	3.7	5.5
QPRT	QPRTase	ENSG00000103485	"Quinolinate phosphoribosyltransferase"	Q15274	16	29679008-29698699	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 61.2"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 349.5;Extravillous trophoblasts: 260.2;Hepatocytes: 304.1;Proximal tubular cells: 417.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.6;monocytes: 7.7"	"Cell line enhanced"	"Detected in many"		"EFO-21: 98.7;Hep G2: 41.2"									"HPA011887, HPA076010"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA		230000	Vesicles		"HPA011887: AB_2668555, HPA076010: "	"prognostic unfavorable (5.10e-5)"	"unprognostic (2.00e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (9.31e-4)"	"unprognostic (1.44e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.58e-2)"	3.2	36.4	6.1	3.0	5.2	1.1	2.4	1.6	5.8	17.9	10.8	4.4	43.3	20.0	12.7	44.3	1.3	14.9	4.9	11.3	4.9	7.5	40.1	61.2	4.7	2.9	7.9	7.5	15.3	22.9	6.1	2.6	24.3	10.0	4.4	5.2	12.6	15.0	19.4	1.5	1.6	24.1	4.7	6.4	5.3	2.7	3.1	2.6	3.7	2.2	0.3	2.1	5.9	5.1	0.1	4.6	1.2	7.7	0.5	1.4	2.2	0.1	0.2	9.4	10.3	1.6	3.9	23.1	0.9	0.9	1.5	1.9	23.6	16.8	0.4	98.7	1.8	1.5	0.1	3.2	0.1	0.8	0.1	2.1	4.8	0.3	41.2	9.0	0.7	2.0	12.3	0.2	0.8	0.0	2.3	0.0	4.6	12.1	0.5	0.0	22.9	3.0	16.8	28.7	0.5	0.0	13.3	2.8	9.3	8.6	0.7	7.6	15.4	0.0	26.8	19.8	16.1	20.0	21.5	0.1	0.4	3.9	0.1	0.0	0.3	0.7	3.1	0.7	1.7	1.5	0.0	3.7	0.4	1.3	4.7	1.4	0.1	0.9	1.0	4.6	0.1	0.1	0.7	1.2	0.5	7.7	2.6	0.8	2.2	6.1	5.2	1.6	5.8	4.9	7.5	7.9	7.5	10.0	2.6	8.9	22.7	18.6	9.6	3.2	1.5	34.8	7.6	0.0	0.0	61.1	0.0	349.5	43.1	0.9	0.0	2.8	125.5	0.0	48.0	260.2	17.5	2.9	4.7	304.1	118.1	6.4	27.2	11.1	13.0	0.0	27.0	12.3	40.5	5.4	45.2	20.3	17.4	77.2	25.5	417.3	3.5	6.5	11.3	0.5	2.5	1.8	180.3	6.4	95.6	6.4
RBAK	ZNF769	ENSG00000146587	"RB associated KRAB zinc finger"	Q9NYW8	7	5045821-5069488	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071231			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA071231: AB_2686370"	"unprognostic (2.82e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.04e-1)"	"unprognostic (4.32e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.84e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.66e-2)"	"unprognostic (6.12e-3)"	"unprognostic (5.75e-2)"	7.6	7.3	7.1	15.0	11.6	5.8	10.7	19.0	10.6	9.2	8.3	5.9	12.0	7.9	9.6	9.7	14.4	8.4	7.5	7.7	9.4	8.3	8.8	12.0	7.7	16.5	8.8	11.6	9.7	11.0	17.5	11.6	8.1	8.7	9.1	9.1	6.2	11.0	14.2	7.9	10.7	9.8	8.9	7.9	10.6	8.8	6.0	11.0	20.0	10.3	15.1	11.7	11.1	10.0	1.7	1.9	1.7	1.8	2.0	3.0	0.6	7.7	6.1	8.5	15.7	6.2	5.8	7.0	4.9	3.9	4.9	5.8	7.4	5.0	9.4	4.2	5.7	9.3	9.8	9.4	7.7	7.6	2.0	6.7	6.7	7.8	6.2	6.6	11.6	8.2	5.7	9.3	4.8	11.0	7.2	4.8	5.5	14.1	3.4	6.1	13.9	2.8	10.5	13.4	2.7	6.3	4.6	13.8	6.9	5.8	10.2	8.7	14.4	7.0	11.7	10.3	11.4	7.1	13.7	4.0	5.9	9.4	6.7	8.1	10.5	8.3	8.4	5.9	8.5	7.6	0.0	0.9	1.7	2.4	1.8	3.0	1.7	1.8	1.7	1.5	1.3	2.2	1.8	0.1	2.0	0.4	1.9	1.2	0.6	7.1	11.6	19.0	10.6	9.4	8.3	8.8	11.6	8.7	11.0	0.0	5.1	5.4	3.1	3.8	7.7	11.5	5.1	4.0	6.8	0.0	9.8	2.2	1.7	5.3	0.8	4.3	4.9	23.3	5.1	1.8	4.2	4.6	5.7	4.0	3.1	20.6	4.7	9.2	7.9	1.0	7.5	2.5	3.3	1.8	5.2	5.0	5.2	3.6	8.1	3.7	7.4	0.0	5.2	4.1	3.3	6.0	1.6	6.9	5.6	3.5
SIRT6		ENSG00000077463	"Sirtuin 6"	Q8N6T7	19	4174109-4182604	"Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 70.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049729, HPA071776"	Supported		Supported	Nucleoplasm		No	No			Nucleoplasm		"HPA049729: AB_2680865, HPA071776: AB_2686445"	"unprognostic (4.58e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.36e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (2.28e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.93e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.13e-2)"	"unprognostic (7.27e-3)"	"unprognostic (4.42e-2)"	"unprognostic (5.84e-2)"	"prognostic favorable (9.13e-4)"	"unprognostic (5.17e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (2.58e-4)"	9.5	11.7	9.4	14.6	11.5	17.8	8.0	15.2	16.3	9.0	26.3	11.0	14.8	19.3	10.6	11.9	11.1	8.9	9.9	11.4	9.5	9.0	12.1	14.2	8.7	12.7	10.8	8.5	8.1	17.3	9.4	13.4	12.1	8.2	12.0	15.3	10.9	12.1	11.9	10.2	13.0	18.4	8.0	7.9	15.1	15.3	6.6	7.0	14.4	10.7	10.0	11.9	8.1	8.9	10.7	14.1	12.4	16.2	5.1	12.0	8.0	14.1	9.6	4.9	6.1	3.8	3.5	7.6	6.9	5.2	5.9	5.2	6.4	5.4	9.2	7.6	4.6	5.4	9.1	2.7	7.6	0.9	17.3	5.4	3.8	5.1	5.8	8.6	9.7	14.9	4.8	6.0	6.1	3.8	4.7	5.2	8.7	8.4	21.1	3.1	10.7	13.4	10.2	8.3	5.3	8.9	10.5	4.5	10.4	5.6	6.4	6.5	10.5	6.2	5.9	13.3	2.0	5.9	12.9	7.9	6.0	6.1	21.0	10.2	26.7	14.0	10.0	12.0	15.6	7.2	5.2	13.4	11.3	11.6	16.2	6.5	10.5	7.8	9.3	14.1	10.7	6.9	6.5	12.4	5.1	12.5	11.9	12.0	8.0	9.4	11.5	15.2	16.3	9.5	9.0	10.8	8.5	8.2	7.0	11.9	8.2	13.7	8.9	9.2	10.5	2.8	10.2	8.1	9.1	5.2	17.7	19.3	11.6	28.5	1.3	6.6	70.3	0.0	23.0	20.0	8.5	7.5	5.7	6.6	21.6	12.7	25.3	14.1	8.7	1.4	10.6	14.0	5.0	34.3	23.1	10.3	25.4	29.8	7.8	11.6	13.0	0.0	8.5	7.0	9.1	11.0	21.4	10.5	24.3	11.1
